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Enterohemorrhagic E.coli O157: H7 (EHEC) has emerged as one of the leading causes of food 
borne illness and pediatric diarrheal disease in the United States. The EHEC associated life-
threatening hemolytic uremic syndrome in human patients is linked to the expression of several 
virulence factors of the pathogen, especially verotoxins. Verotoxins (VT) or shiga like toxins (Stx) 
are the major virulence factors elaborated by EHEC. Even after 30 years of research on EHEC 
epidemiology and pathogenesis, little advancement has been made in disease prevention and 
treatment against the bacterium. One of the main limitations in treating EHEC infection is the 
contraindicated usage of antibiotics, since they have been reported to exacerbate verotoxin-
mediated HUS and renal failure.  Therefore, there is a crucial need for the development of alternate 
interventions for preventing and treating EHEC infections in humans. EHEC being a foodborne 
pathogen, controlling its persistence in meat processing facilities and inactivating the pathogen in 
high-risk foods such as undercooked ground beef products could potentially reduce food-borne 
disease outbreaks in humans. Moreover, identifying drugs that attenuate EHEC virulence, 
especially verotoxins would reduce the severity of infection and improve disease outcome in 
humans.  This dissertation investigated the potential of a phytochemical, rutin (RT), and an 
essential mineral, selenium (Se), for targeting EHEC from both these aspects, thereby reducing 
risks to humans. Specifically, the efficacy of Se in reducing EHEC biofilms on food contact 
surfaces, and the efficacy of RT for decreasing EHEC in undercooked ground beef were 
investigated. Selenium was found to be effective in inhibiting and inactivating EHEC on abiotic 
surfaces. In addition, coating of stainless steel surface with Se nanoparticles exerted significant 
antibiofilm effect against EHEC (P < 0.05). On the other hand, RT significantly increased heat 
inactivation of EHEC in undercooked ground beef patties without adversely affecting meat color 
and shelf-life. In addition, mechanistic investigations on the anti-virulence property of these 
natural antimicrobials revealed that Se and RT significantly decreased both intracellular and 
extracellular verotoxin synthesis (P < 0.05). In addition, Se decreased EHEC toxin receptor 
expression in host cells, whereas RT competed for the receptor binding sites on the toxin. 
Moreover, RT decreased EHEC motility and adhesion to cultured intestinal epithelial cells (P< 
0.05). Subsequently, the protective effect of RT and Se against EHEC was validated in vivo using 
Caenorhabditis elegans model. Rutin significantly increased the survival of EHEC-infected C. 
elegans compared to control worms, where the survivability was increased by ~ 65% (P < 0.05). 
However, Se was lethal to C. elegans, and at very low sub-lethal dose failed to protect the worms 
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Enterohemorrhagic Escherichia coli O157: H7 (EHEC) is a subset of Shiga-like toxin-
producing E. coli, which causes hemorrhagic colitis and hemolytic uremic syndrome (HUS) in 
humans.   Because of its low infectious dose in humans (2–2,000 cells) (Buchanan, 1997; Strachan 
et al., 2005), EHEC poses a significant public health hazard. EHEC associated foodborne illnesses 
are estimated to cost the US economy ~ 200 million dollars annually (Hoffman et al., 2015). 
Although several foods have been implicated as vehicles of infection, the majority of EHEC 
foodborne outbreaks are linked to the ingestion of undercooked ground beef products (Armstrong 
et al., 1996; Hussein, 2007). Cattle are the most common source of EHEC, excreting the pathogen 
in feces, thereby contaminating foods, water and the environment (Croxen et al., 2013; Shere et 
al., 1998; Naylor et al., 2003). 
EHEC is known to form persistent biofilms in diverse food processing environments 
(Doyle, 1991, Buchanan, 1997, Vogeleer et al., 2015). These biofilms are recognized as a potential 
and continuous source of food contamination and have been linked to foodborne outbreaks 
(Costerton et al., 1999, Janssens et al., 2008).  Since common disinfectants and sanitizers are not 
fully effective in inactivating biofilms, there is a need for identifying effective treatments for 
controlling biofilms in food processing environments. 
The United States Department of Agriculture (USDA) has established a zero tolerance 
policy for EHEC in ground beef and recommended that beef patties should be cooked to an internal 
temperature of 71.1°C (160°F) to ensure complete pathogen inactivation (USDA, 1998). However, 
due to the lack of homogeneity in patty composition, and temperature monitoring difficulties, the 
recommended internal temperature may not be uniformly attained. Additionally, the use of 
thermometers for cooking beef patties by consumers is limited, and most consumers determine the 
doneness of beef patties by observing the color and texture of cooked meat, which are not accurate 
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indicators of beef doneness. Therefore, it is beneficial to include an antimicrobial hurdle to ensure 
inactivation of EHEC in undercooked ground beef patties.  
Verotoxins (VT) are the key virulence factor that defines EHEC pathogenesis, and are 
responsible for causing HUS in humans (Sakagami et al., 2001). EHEC produces verotoxin 1 
and/or verotoxin 2, which are encoded by stx1 and stx2, respectively. Verotoxins belong to AB5 
toxin family with A and B subunits. The pentameric B subunit binds to the target cell glycolipid 
receptor, globotriaosylceramide (Gb3), and gets internalized by receptor-mediated endocytosis. 
After internalization, the subunit A interacts with 60S ribosomal subunit and inhibits protein 
synthesis, thereby leading to cell death (Weeratna and Doyle, 1991; Tam and Lingwood, 2007).  
Therefore, an adequate expression of Gb3 receptor on host cells is a pre-requisite for toxin-
mediated pathogenesis. The total verotoxin produced by EHEC includes two components, namely 
extracellular and intracellular. EHEC cells release the extracellular verotoxin component directly 
into the growth environment, whereas the intracellular portion gets accumulated in the bacterial 
cells, and is released when bacterial cells are lysed (Yuk and Marshall, 2003, 2004, 2006). These 
Stx1 and Stx2 toxins are encoded on prophages and are integrated into EHEC genome. The lytic 
cycle of these prophages gets stimulated during bacterial stress, leading to increased release of the 
intracellular toxin from lysed bacterial cells through SOS response. Therefore, the use of 
antibiotics to treat EHEC infections is contraindicated (Croxen et al., 2013).  
Since the use of antibiotics is linked to increased mortality (Su, 1995) by increasing 
intracellular VT release (Su, 1995; Suwalak and Voravuthikunchai, 2009), the current treatment 
options for EHEC infections are mainly supportive. These include fluid resuscitation, peritoneal 
dialysis, plasma exchange and appropriate emergency care strategies for complications such as 
renal failure and anemia (Ho et al., 2012). Moreover, antibiotics can negatively affect the normal 
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gut flora which in turn can lead to EHEC overgrowth (Su, 1995). Thus, there is a critical need for 
alternate approaches for controlling EHEC infection in humans. A relatively new strategy which 
is being increasingly investigated for combating infectious diseases involves targeting microbial 
virulence rather than growth, where a pathogen’s specific mechanisms critical for causing infection 
or disease symptoms in hosts are inhibited (Rasko and Sperandio, 2010; Khodaverdian et al., 
2013). Since anti-virulence agents are neither bacteriostatic nor bactericidal, they exert a reduced 
selection pressure for the development of bacterial drug resistance (Rasko and Sperandio, 2010; 
Hung et al., 2005; Cegelski et al., 2008; Mellbye et al., 2008; Clatworthy et al., 2007), and are 
minimally deleterious to the host gut microflora.  
Metals have been used as antimicrobial agents for centuries. However, their usage in 
medicine and agriculture declined after the discovery of antibiotics. However, due to the 
emergence of multidrug-resistant pathogens and a shortage of new antibiotics, the use of 
antimicrobial metals is now undergoing a period of resurgence (Lemire et al., 2013).  Many 
transition metals and metalloids such as copper, silver, and gallium have been reported as effective 
antimicrobials and anti-biofilm agents against E. coli, Salmonella, Pseudomonas aeruginosa, and 
Staphylococcus aureus (Lemire et al., 2013, 2015; Warnes et al., 2012; Wakshlak et al., 2015). 
Selenium (Se) is a naturally occurring essential microelement recommended for daily intake by 
the Food and Drug Administration (FDA).  Selenium is present in a wide variety of foods and is 
available as a dietary supplement. Sodium selenite (Na2SeO3) is a commonly used dietary 
supplement containing Se, with proven antifungal and antibacterial properties (Soriano-Garcia, 
2004; Kumar et al., 2010).   
Phytochemicals have been an important ingredient of traditional and herbal medicine. 
Extensive research has documented a wide range of beneficial properties with phytochemicals, 
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including antiseptic, anti-inflammatory, antioxidants and antimicrobial effects (Deans and Ritchie; 
1987; Baratta et al., 1998a, b; Alma et al., 2003). Rutin (RT, quercetin-3-rhamnosyl glucoside) is 
a natural flavone derivative present in buckwheat, asparagus, rhubarb, and berries (Kreft et al., 
2006). Various pharmacological effects of RT, including anti-allergic, anti-inflammatory, 
antitumor, antibacterial, antiviral and antiprotozoal properties have been reported (Yang et al., 
2006).  
Several animal models have been proposed to investigate the pathogenesis of EHEC. 
Recently, the nematode Caenorhabditis elegans has been well recognized as a naturally infected 
and genetically tractable animal host to study bacterial pathogenesis (Ritchie et al., 2013), thereby 
making it suitable for determining host-pathogen interactions. Moreover, the nematode has been 
identified as an efficient model to screen for novel anti-infectives in enteric bacterial infections. 
Based on published literature on the antimicrobial properties of Se and RT, and preliminary 
research conducted in our laboratory, it is hypothesized that Se and RT are effective in attenuating 
EHEC virulence by reducing the expression of verotoxins and impeding host cell receptor–toxin-
mediated pathogenesis. In addition, Se is effective as an anti-biofilm agent on food contact 
surfaces, and RT decreases heat resistance of EHEC in ground beef. The specific objectives of this 
dissertation include: 
1. Investigate the effect of Se in inhibiting and inactivating EHEC biofilms on food contact 
surfaces. 
2. Investigate the effect of RT in enhancing thermal destruction of EHEC in undercooked ground 
beef.  
3. Determine the effect of Se in reducing EHEC verotoxin production and Gb3 receptor 
expression on host cells. 
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4. Determine the effect of RT in reducing EHEC verotoxin production and toxin binding to Gb3 
receptor. 






















































Escherichia coli is a Gram-negative, chemoorganotrophic, oxidase-negative, commensal 
bacterium, which constitutes ~ 1% of the gastrointestinal population of the mammalian gut 
(Brenner et al., 2005).  Escherichia coli was first described by the German physician, Dr. Theodor 
Escherich in 1885 (Escherich, 1989). It is a member of Enterobacteriaceae, closely related to 
Salmonella, Serratia, and Klebsiella (Brenner and Farmer, 2005). Physiologically, E. coli is a 
facultative anaerobe possessing the ability to sustain life with or without oxygen. Furthermore, its 
ability to survive short exposures of pH levels as low as 2.0 enables the successful passage of E. 
coli through the acidic stomach environment prior to its intestinal colonization (Small et al., 1994). 
Owing to its hardiness, versatility, and ease of handling, E.coli has been one among the most 
thoroughly studied microorganisms in the history of biological sciences (Blount, 2015; Alteri and 
Mobley, 2012). The findings utilizing this bacterium have shed light on understanding and 
illustrating fundamental genetic and biochemical evolution in bacteria. Moreover, several E.coli 
strains have been identified as platforms for genetic engineering for a number of applications, 
including recombinant protein production (Richins et al., 1997; Terpe, 2006), biosensor 
development (Chalova et al., 2009, 2010), and as indicator probes in biotechnological studies 
(March et al., 2003; Sanchez and Golding, 2013).  
Escherichia coli is a constituent of the normal flora of the intestinal tract of humans and 
other warm-blooded animals (Drasar and Hill, 1974). Although most E. coli are believed to be 
normal commensals, there are pathogenic strains of E. coli associated with human and animal 
diseases. Many of the pathogenic strains cause enteric diseases ranging from mild diarrhea to 
severe dysentery; some colonize the urinary tract causing cystitis or pyelonephritis, or others may 
even cause extraintestinal septicemia and meningitis. These pathogenic strains are diverse and 
differ from those that predominate the enteric flora of healthy individuals. The acquisition of 
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multiple virulence determinants such as toxins, adhesins, and effector proteins in commensal E. 
coli can occur through the transfer of mobile virulence plasmids, phages, and pathogenicity islands 
(PAI), and this is believed to have led to the evolution of pathogenic E.coli. To date, eight E.coli 
pathovars have been identified. They are broadly classified as either diarrheagenic E. coli or 
extraintestinal E. coli (ExPEC). The six diarrheagenic pathovars include enteropathogenic E. coli 
(EPEC), Enterohemorrhagic E. coli (EHEC), enterotoxigenic E. coli (ETEC), enteroinvasive E. 
coli (EIEC), enteroaggregative E. coli (EAEC) and diffusely adherent E. coli (DAEC). The two 
most common ExPEC include uropathogenic E. coli (UPEC) and neonatal meningitis E. coli 
(NMEC) (Croxen and Finlay, 2010). Within each pathotype classification, E. coli strains are 
further characterized based on O-antigen (lipopolysaccharide), H-antigen (flagellar), and K-
antigen (capsular) (DebRoy et al., 2011). 
Enterohemorrhagic Escherichia coli (EHEC) 
Enterohemorrhagic Escherichia coli (EHEC) has emerged as the predominant cause of bloody 
diarrhea and hemorrhagic colitis in humans, occasionally resulting in life-threatening systemic 
complications, including hemolytic uremic syndrome (HUS) and renal failure. Being a food and 
waterborne enteric pathogen, EHEC has been associated with numerous outbreaks globally, 
constituting a serious public health threat. Among the 380 different EHEC serotypes, the antigenic 
variant O157: H7 is commonly associated with foodborne disease outbreaks in the United States. 
The serotype O157: H7 was first implicated in a foodborne illness reported in 1982, and during 
the subsequent 10 years, approximately 30 outbreaks were recorded in the US (Griffin and Tauxe, 
1991). However, O157: H7 received considerable attention after a large foodborne disease 
outbreak traced back to the consumption of undercooked, contaminated hamburgers served at a 
fast-food restaurant chain in the Western United States (CDC, 1993). More than 700 people in four 
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different states were infected, and there were 51 HUS cases and four deaths (Feng, 1995). Since 
that outbreak, enhanced surveillance systems have been implemented and awareness about the 
pathogen has increased among physicians, clinical microbiologists, public health scientists, and 
consumers. There have been 554 outbreaks, 12250 illnesses, 2005 hospitalizations and 35 deaths 
linked to this pathogenic E.coli (CDC, 2017).  
Evolution of EHEC 
EHEC is a subset of the larger group of Shiga-like toxin producing E. coli (STEC), which 
produce Shiga-like toxins (Stx). For epidemiological reasons, the toxins are alternatively referred 
to as verotoxins (VT), and the organisms that produce these toxins as VTEC. Evolutionarily, the 
O157: H7 serotype is most closely related to an enteropathogenic E. coli clone of serotype O55: 
H7, a non-Stx-producing strain associated with infantile diarrhea, although it is a distinct clone 
distantly related to other Stx-producing EHEC (Feng et al., 1998). Feng and colleagues formulated 
an evolutionary model from genotypic and phenotypic data collected, which explained the series 
of steps that led to the emergence of O157: H7. Based on the model’s assumption, during 
divergence, the gain of most functions occurred via lateral or horizontal transfer of mobile gene 
elements. Interestingly, the loss of function during the evolution greatly exceeded that of gain of 
function for metabolic genes in the serotype. This observation helped further specific predictions 
about the history of descent and the order of acquisition of virulence factors in the emergence of 
the EHEC pathotype. The evolutionary steps outlined in the model began with the ancestral or 
primitive EPEC-like serotype with the ability to express β glucuronidase (GUD+) and ferment 
sorbitol (SOR+) similar to most present day E.coli. Additionally, EPEC-like O55:H7 ancestor 
carried the gene, eaeA and acquired the Stx2 gene by transduction from a toxin-converting 
bacteriophage, resulting in a Stx2-producing O55:H7 strain. From this ancestral strain, the somatic 
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antigen changed from O55 to O157, giving rise to a hypothetical O157:H7 Stx2-producing 
ancestor that retained the GUD+ SOR+ phenotype. Further divergence caused the lineage to lose 
the ability to ferment sorbitol and acquired the Stxl gene, probably by phage conversion. This led 
to an intermediate ancestral stage still possessing the primitive traits, GUD+ and Stx2+ along with 
the derived states (SOR-, Stx1+). Later in the evolutionary tree, the clones lost the GUD activity, 
producing the immediate ancestor of the common O157: H7 clone (ET1), which spread globally 
(Feng et al., 1998).  
EHEC virulence 
Karmali and colleagues in the late 19th century found that patients presented with diarrhea 
and HUS were positive for a toxin capable of inducing irreversible cytotoxicity in cultured Vero 
cells (African green monkey kidney epithelial cells), and identified EHEC as the pathogen 
(Karmali et al., 1985). The toxin was found to be structurally and antigenically similar to the toxin 
produced by Shigella dysenteriaie type 1, which resulted in the name, Shiga-like toxin. EHEC 
strains produce two immunologically distinct toxins, Stx1 or Stx2, alone or both. Nevertheless, 
O157: H7 strains that produce Stx2 are associated with an increased risk of systemic complications 
(Donohue-Rolfe et al. 2000). As mentioned, Stx1 is nearly identical to the S. dysenteriae toxin, 
differing by a single amino acid, whereas Stx2 was initially distinguished from type 1 by distinct 
antiserum neutralization (Melton-Celsa, 2014; Bryan et al., 2015). Both shiga-like toxins are 
produced via a single operon containing two genes, stxA and stxB, and at least one promoter. The 
Shiga-like toxin or verotoxin operon(s) are found to be embedded within the genome of integrated 
lambdoid prophages, and they are believed to have been acquired either by horizontal transmission 
via phage and/or by direct inheritance (Garcia et al., 2010; Bryan et al., 2015). Shiga-like toxins 
are AB5 toxins, composed of a single copy of the ~ 32 kDa A component (encoded by stxA) and 
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5 copies of the ~ 8 kDa B component (produced by stxB). The A component bears the enzymatic 
activity of the toxin, whereas each B subunit possesses three binding sites for the toxin receptor 
(Fraser et al., 1994, 2004). Other biotoxins, including pertussis toxin, cholera toxin, and heat-labile 
enterotoxin of enterotoxigenic E coli also belong to the AB5 family (Beddoe et al., 2010). 
Environmental stressors, including antibiotics induce the activation of the operon promoters, 
which are embedded within the prophage genome. Thus, upon induction, Stx-encoding 
bacteriophages can increase the toxin production. Therefore, until last decade, it was assumed that 
the prophage lytic cycle is strongly linked to the toxin production. However, recently there is some 
evidence suggesting that Stx can be delivered via outer membrane vesicles (OMVs) without cell 
lysis (Bielaszewska et al., 2017; Yokoyama et al., 2000). Nevertheless, the mechanisms by which 
the Stxs are delivered to the systemic circulation have not been understood fully. Despite the 
knowledge gap, Stx remains as the key virulence factor that defines EHEC pathogenesis in humans 
(Sakagami et al., 2001).  
Shiga-like toxins or verotoxins use a carbohydrate moiety for endocytic transport into their 
target cells. The pentameric B subunit binds to the host cell glycolipid receptor, 
globotriaosylceramide (Gb3), and gets internalized by receptor-mediated endocytosis. Therefore, 
adequate expression of Gb3 receptor on host cells is a pre-requisite for toxin-mediated 
pathogenesis. However, the expression of Gb3 is restricted to only certain tissues, and the cell 
types expressing Gb3 vary among hosts. For example, Gb3 content is found abundantly in the 
microvascular glomeruli and proximal tubule cells of the kidney, which justifies the renal 
pathology of HUS. Gb3 is also found in intestinal microvascular endothelial cells, including colon 
and central nervous system. Therefore, during infection with STEC, main toxin target sites are the 
vascular endothelium of the colon (Omhi et al., 1998), kidneys and the central nervous system 
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(Ren et al., 1999). Moreover, Gb3 is expressed in platelets and constitutes the rare Pk antigen 
present on erythrocytes (Steffensen et al., 2000). In the immune system, Gb3 represents a 
lymphocyte differentiation antigen, termed CD77, which is expressed in a subset of germinal 
center B lymphocytes (Mangeney et al., 1991). It is also known that Gb3 expression is often 
increased in cancer cells (Engedal et al., 2011). However, the precise physiological role of Gb3 is 
not clear, and also the reason behind the restricted Gb3 expression in certain tissues is unknown.  
After receptor-mediated internalization, verotoxin gets transported through early 
endosomes and recycling endosomes, and to the Golgi apparatus. From the Golgi, the toxin is 
transported retrogradely to the endoplasmic reticulum, where it is catalytically active. The A 
subunit is released and translocated to the cytosol (Sandvig et al., 1989; 2010), which then interacts 
with 60S ribosomal subunit and inhibits protein synthesis, thereby leading to cell death (Weeratna 
and Doyle, 1991; Tam and Lingwood, 2007).  The A subunit exhibits an RNA N-glycosidase 
activity against 28s rRNA, which induces apoptosis (Sandvig et al., 2010). Consequently, any 
interventions that interfere any of these transport factors could impede proper intracellular transit 
of verotoxin and protect cells against the cytotoxic action of the toxin. For example, Stechmann et 
al. (2010) identified two low molecular weight substances called Retro-1 and Retro-2, which 
inhibited the retrograde transport of Stx1B from endosomes to the Golgi apparatus without 
affecting the compartment integrity and endogenous retrograde transport. This in turn 
phenotypically reduced the cytotoxicity induced by Stx1 and Stx2 in A459 and HeLa cells, when 
added 30 min prior to challenge with the toxins (Stechmann et al., 2010). 
EHEC pathogenesis is however not solely due to toxin-mediated effects, and the infection 
is initiated by a number of other supporting virulence factors, including adhesins such as intimin, 
flagella, lipopolysaccharides and Type III secretion system. All of these contribute to effective 
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EHEC colonization, marked cytoskeletal rearrangements, disruption of intestinal barrier function, 
downregulation of host inflammatory response, and induction of host cell apoptosis (Barnett 
Foster, 2013). In addition, the large EHEC pO157 plasmid carries a homolog of the lifA gene 
encoding lymphostatin, genes encoding a type II secretion system, catalase-peroxidase (katP), a 
secreted serine protease (espP), and a hemolysin operon (Nataro and Kaper, 1998; Farfan and 
Torres, 2012). 
Epidemiology of EHEC 
Animal reservoirs 
EHEC is a globally important zoonotic enteric pathogen. The first recorded EHEC 
infection in humans was associated with the consumption of contaminated undercooked ground 
beef burgers. Cattle have been recognized as the major reservoir of EHEC (Ferens and Hovde, 
2011). In addition,  EHEC carriage has also been reported in bison and cervids (deer, elk), and 
occasionally in pigs, camelids, rabbits, horses, dogs, cats, zoo mammals such as bears, large cats, 
and various free-living wild species such as raccoons opossums, and rats.  The pathogen has been 
detected at times in the gut of wild or domesticated birds, including, chickens, turkeys, geese, 
ostriches, pigeons, gulls, rooks, and starlings. (Anonymous, 2017).  
The prevalence of EHEC in cattle has been a topic of much research in the late 19th century, 
and the role of several EHEC factors in bovine colonization has been well characterized (Sheng et 
al., 2006). Healthy domesticated ruminants, mainly cattle, and to a lesser extent sheep and goats, 
carry EHEC transiently without manifesting any pathological symptoms (Blanco et al., 1996; 
Gyles, 2007; La Ragione eta l., 2009; Ferens and Hovde, 2011). This is explained by the apparent 
resistance to the systemic effects of verotoxins due to the absence of Gb3 receptors in the bovine 
intestinal tract and the vasculature (Pruimboom-Brees et al., 2000; Hoey et al., 2002).  The primary 
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site of EHEC colonization in cattle is the terminal rectum, particularly an anatomical area within 
the terminal rectum referred to as the recto-anal junction (RAJ (Naylor et al., 2003). Fecal shedding 
of EHEC occurs for a short time (a few days) if individual animals passively shed the pathogen in 
their feces without establishing a colonized state, or sheds the fecal pathogen for a longer time (a 
month or more) if the bacteria colonize and persist in the animal gut (Grauke et al., 2002). Thus, a 
major contributor in animal-to-animal transmission is the high prevalence of EHEC in cattle feces. 
Another important source leading to carcass contamination is cattle hide. The higher the fecal 
shedding of EHEC, the greater the extent of hide contamination, and consequently increased 
contamination of the carcass. This occurs particularly in the summer months, and also in a cattle 
feedlot with a higher percentage of supershedders (Elder et al., 2000). Super shedders are animals 
which harbor a high intestinal load of the pathogen for extended periods of time (Ferens and 
Hovde, 2011).  EHEC carriage in cattle thus leads to human infection through fecal contaminated 
water, meat, produce or by direct contact in petting zoos. Outbreaks have increasingly been 
reported through environmental contamination of water supplies from feces of grazing animals 
(Licence et al., 2001;  Hrudey et al., 2003) and direct contact with farm animals and their feces 
when camping on a farm pasture (Strachan et al., 2001) or during a visit to agricultural and animal 
fairs (Crump et al., 2003).  
Food as a source 
Food has been the predominant transmission route of EHEC since 1982, constituting 52% 
of 350 outbreaks and 61% of ~ 9000 sporadic cases (Rangel et al., 2005). EHEC associated 
foodborne illnesses are estimated to cost the US economy ~ $ 200 million annually (Hoffman et 
al., 2015). Although a variety of foods have been implicated as vehicles of infection, the majority 
of EHEC foodborne outbreaks are associated with the consumption of undercooked ground beef 
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products (Armstrong et al., 1996; Hussein, 2007). Interestingly, in an American case–control study 
on sporadic EHEC cases, a strong positive association was reported with eating “pink hamburgers” 
(Kassenborg et al., 2004). Among the 183 foodborne outbreaks reported until 2002, the source of 
infection for 75 (41%) was ground beef, whereas the remaining 38 (21%) were contributed from 
produce, 11 (6%) from other beef products,7 (4%) by dairy products and rest unknown (Rangel et 
al., 2005). In addition, pulsed field gel electrophoresis showed that several human EHEC isolates 
were found to be indistinguishable to those from undercooked retail burgers (CDC, 1997; Strachan 
et al., 2006).  
The USDA has established a zero tolerance policy for EHEC in ground beef, and 
recommended that beef patties be cooked to an internal temperature of 71.1°C (160°F) to ensure 
complete pathogen inactivation (USDA, 1998). Based on the degree of doneness, cooked patties 
can be classified as rare (60°C/140°F), medium-rare (65°C/149°F), medium (71.1°C/160°F) or 
well done (77°C/170.6°F) (Marksberry et al., 1993). In order to ascertain that the required internal 
temperature (71.1°C) is attained during cooking of ground beef patties, the USDA advised 
consumers to use a meat thermometer. However, because of the lack of homogeneity in patty 
composition, and temperature monitoring difficulties, there is the possibility that the recommended 
internal temperature may not be uniformly attained (D’Sa et al., 2000). Further, the use of 
thermometers for cooking beef patties by consumers is limited (NCBA, 1999; McCurdy et al., 
2005) due to the inconvenience of the procedure, consumer uncertainty, and a lack of consumer 
confidence in a thermometer’s ability to ensure food safety (USDA, 1998; Research Triangle 
Institute [RTI], 2001; McCarty, 2008).  
According to a survey conducted by the USDA-ERS, approximately 20% of the US 
population preferred eating rare or medium-rare patties at home, restaurants, and cafeterias 
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(Ralston, 2002). The same study revealed that at the internal cooking temperatures specified for 
rare and medium rare cooked patties, EHEC numbers did not decline significantly. Moreover, most 
consumers determine the doneness of beef patties by observing the color and texture of cooked 
meat. However, color is not a good indicator of doneness because ground beef is prone to a non-
typical color change associated with cooking called premature browning (PMB) (Claus, 2007), 
where meat appears fully cooked despite not having achieved a safe internal temperature. Thus, 
PMB in ground beef can lead to inadequate cooking by consumers who are misled by the cooked 
color (Warren et al., 1996a, b), potentially allowing EHEC survival.  Killinger et al. (2000) 
reported that PMB incidence averaged about 47% in ground beef purchased from retail stores. 
When compared to steaks and roasts, ground beef is more susceptible to PMB because of 
accelerated oxidation of the meat pigment, myoglobin that occurs as a result of grinding. Since the 
infectious dose of EHEC in humans is low (2–2,000 cells), it is important to avoid undercooking 
of beef patties (Buchanan, 1997; Strachan et al., 2005).  
Besides, ground beef, other common food products implicated with EHEC outbreaks in the 
United States include lettuce, alfalfa sprouts, spinach, raw milk, unpasteurized dairy products and 
dry cured salami (Hillborn et al., 1999; Breuer et al., 2001). Apple cider was also identified as a 
vehicle of EHEC in several previous outbreaks reported since late 1900’s (Zhao et al., 1993; Besser 
et al., 1993; Hilborn et al., 2000; Mamadou et al., 2011). Recently, unpasteurized apple juice and 
cider have received considerable attention due to local and multistate recalls and outbreaks in 
different parts of the country (Anonymous, 2015). Fresh produce could be contaminated directly 
with feces or indirectly via contaminated irrigation and processing water (during vegetable 
cultivation) (Strachan et al., 2006).  
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The prevalence of EHEC biofilms is another major concern in the food industry. Biofilms 
are aggregates of microorganisms adhered to biotic or abiotic surfaces embedded by a self-
produced extra-polymeric matrix, which in turn facilitates survival in a hostile environment 
(Costerton et al., 1999). The presence of EHEC biofilms in food processing environments, animal 
slaughterhouses and meat packing plants has been well documented, and these biofilms possibly 
act as continuous sources of contamination of food products (Kumar and Anand, 1998; Aslam et 
al., 2004; Rivera-Betancourt et al., 2004; Sharma and Bearson, 2013; Vogeleer et al., 2014). 
Studies have shown that contamination of beef carcasses with EHEC could occur during different 
stages of processing such as slaughtering, dressing, chilling or cutting (Bacon et al., 2003; 
Koutsoumanis and Sofos, 2004). The ability of EHEC to form biofilms on different equipment 
surfaces has been linked to the distribution and persistence of EHEC in meat processing plants 
(Carpentier and Cerf, 1993; Dewanti and Wong, 1995; Aslam et al., 2004; Rivera-Betancourt et 
al., 2004). Furthermore, many EHEC outbreaks associated with the consumption of fresh produce, 
such as cabbage, celery, radish sprouts, lettuce, spinach, and tomatoes have also been linked to 
surface colonization by EHEC biofilms (Beuchat 2002; Brandl 2006).  
Human transmission 
Although EHEC transmission to humans is principally via consumption of contaminated 
food and water, interpersonal spread can also contribute to outbreaks (Ryan et al., 1986; Carter et 
al., 1987). Person-to-person transmission of EHEC contributing to disease spread during outbreaks 
usually occurs via the fecal-oral route. Infants and young children tend to shed the pathogen 
although humans are not believed to be a reservoir of EHEC. According to Rangel et al (2005), 
until 2002, 50 outbreaks were reported via the fecal-oral route of transmission between ill and 
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immunocompromised individuals. These outbreaks mainly included child-care centers, individual 
residences, community centers, school and residential facilities.  
Treatment strategies against EHEC infection  
Currently, supportive care measures only are recommended for treating EHEC infections 
and antibiotics are contraindicated. The conventional antibiotic usage has been reported to 
exacerbate verotoxin-mediated cytotoxicity. Several studies observed increased chance of 
developing renal failure in children on antibiotic therapy for HUS associated with EHEC infection 
(Wong et al., 2000; Zimmerhackl, 2000; Safdar et al., 2002; Tarr et al., 2005). Antibiotics enhance 
the replication and expression of stx genes encoded within a chromosomally integrated lambdoid 
prophage genome resulting in increased verotoxin production. It also causes phage-mediated lysis 
of EHEC cell membrane, allowing the release and dissemination of the toxin into the environment 
(Karch et al., 1999; Matsushiro et al., 1999; Wagner et al., 2002). Moreover, antibiotics can 
negatively affect the normal gut flora, which in turn can lead to EHEC overgrowth (Su, 1995). 
Furthermore, several drugs, including antimotility agents, narcotics, and non-steroidal anti-
inflammatory medications are not advised for EHEC-infected patients (Tarr et al., 2005). 
Generally, HUS is manifested as acute renal failure, hemolysis, and thrombocytopenia with 
the disruption of clotting cascade and perturbation of fluid and electrolyte balance, potentially 
leading to stroke (Ruggenenti et al., 2001; Tarr, 2005). The syndrome is, therefore, better managed 
by a multi-targeted approach, which includes fluid resuscitation, peritoneal dialysis, plasma 
exchange and appropriate emergency care strategies for complications such as renal failure and 
anemia (Holtz et al., 2009; Ho et al., 2013). As alternate treatment modalities, studies have 
investigated monoclonal antibodies (MAbs) such as Urtoxazumab,  antithrombotic agents, plasma 
exchange therapies (PLEX), tissue-type plasminogen activator, oral Stx-binding agents (Synsorb 
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PK), and eculizumab for their efficacy in the management of HUS (Lopez et al., 2010; Rocha et 
al., 2010; Trachtman et al., 2012; Goldwater and Bettelheim, 2012). Despite these studies, data 
supporting the use of the aforementioned treatment strategies for helping patients recover from the 
illness are still lacking. Thus there is an urgent need for the development of alternative treatment 
approaches for treating and controlling EHEC infections in humans. 
Recently, new approach of targeting virulence of a pathogen for controlling infectious 
diseases is widely explored. Since virulence factors of pathogens contribute to the establishment 
of infection in a host, inhibition of these factors could prevent disease progression (Defoirdt, 2016; 
Rasko and Sperandio, 2010; Khodaverdian et al., 2013). Thus, a viable strategy for controlling 
EHEC infections is the use of drugs against the virulence factors of the pathogen. Moreover, this 
class of drugs presents a lesser selective pressure on development of bacterial resistance compared 
to traditional antimicrobial therapy (Rasko and Sperandio, 2010; Hung et al., 2005; Cegelski et al., 
2008; Mellbye et al., 2008; Clatworthy et al., 2007). Therefore, novel approaches for treating 
EHEC infections in humans could be directed against verotoxins, toxin receptor, and their 
interaction, thereby reducing the cellular uptake of toxins and downstream pathogenesis. 
Antimicrobial metals 
Metals have been used as antimicrobial agents since antiquity. Copper and silver were used 
to disinfect and preserve water, milk, and vinegar by North American settlers. Japanese soldiers 
used these metals as antimicrobial agents during the Second World War to prevent the spread of 
dysentery (Alexander, 2009; Borkow et al., 2009). However, their usage in medicine and 
agriculture decreased gradually after the discovery of antibiotics.  Owing to the emergence of 
antibiotic resistant pathogens and a dearth of new antibiotics under discovery, this decade is 
witnessing the resurgence in antimicrobial metal research. Many transition metals and metalloids 
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such as copper, silver, and gallium have been reported as effective antimicrobials and anti-biofilm 
agents against E. coli, Salmonella, Pseudomonas aeruginosa and Staphylococcus aureus (Lemire 
et al., 2013; Warnes et al., 2012; Wakshlak et al., 2015). The ability of metals to remain stable and 
withstand high temperature and pressure has made them ideal for application in food processing 
area (Murakoshi et al., 2003; Fu et al., 2005). Further, advancements in nanotechnology have 
enhanced the potential of using some metals or their oxides in sizes less than 100 nm. Studies have 
documented selective toxicity of metal nanoparticles to bacterial pathogens with minimal effect 
on human cells, which enhances their potential use in agricultural and food industries (Brayner et 
al., 2006; Jiang et al., 2009; Reddy et al., 2007; Zhang et al., 2007). Thus antimicrobial metals 
offer natural and safe sanitizing agents, food additives, and antimicrobial treatments to reduce 
foodborne pathogens in the food chain continuum. The antibacterial mode of action of metals has 
been elucidated through several approaches during the past decade. These studies indicate that 
there are no exclusive mechanisms by which metals inactivate microbial cells.  However, there 
exist a few well-characterized mechanisms, including the production of reactive oxygen species, 
antioxidant depletion, inactivation of essential bacterial proteins, membrane function impairment 
and genotoxic effects, as discussed in the review by Lemire and colleagues (2013).  
Selenium (Se) is a metalloid, well-recognized as a dietary antioxidant, and its compounds 
are commonly used in nutrition and chemoprevention therapy (Estevam et al., 2015). It is an 
essential component of several enzymes, including glutathione reductase, and is recommended for 
daily dietary intake in humans by the Food and Drug Administration (FDA), with an upper 
tolerable intake level of 400 -800 µg (Sunde, 2012). Several selenium-based formulations such as 
selenomethionine and sodium selenite (Na2SeO3) are available commercially as food 
supplements, anticancer agents, and immune stimulators. The antibacterial and antifungal 
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properties of Se were studied during the early 20th century (Soriano-Gracia et al 2004; Kumar et 
al., 2010). Xi et al (2002) reported potential antibacterial property of four different Se compounds 
on S. aureus using microcalorimetry. In 2011 Vasić et al. (2011) observed that sodium selenite 
affected growth and extracellular protein synthesis in multiple pathogens, including B. subtilis, B. 
mycoides, E. coli, and Pseudomonas spp. These researchers also showed that sodium selenite 
increased the inhibitory effect of antibiotics on all pathogens tested in vitro. Furthermore, anti-
toxigenic effect of Se against Vibrio cholerae was reported recently (Bhattaram et al., 2017). 
Moreover, in vitro studies with Se showed that the essential mineral strongly inhibited spore 
germination, germ tube elongation and mycelial spread in Penicillium expense (Wu et al., 2014). 
Similar results were reported on spore germination in Botrytis cinerea, which causes spoilage in 
tomatoes (Wu et al., 2015). Recently, studies have evaluated the potential of Se to inhibit Ebola 
and other enveloped viruses as well (Lipinski, 2015; Lyons, 2014). During the latest Ebola 
outbreaks, it was identified that a deficiency in Se could lead to increased viral pathogenesis. This 
observation supported the earlier findings of Beck (2007) that adequate intake of Se could protect 
the host against viral infections. 
In a study published in 2015, the biological activity and role of different selenium 
compounds against antibiotic resistant pathogens such as S.aureus were investigated (Estevam et 
al., 2015). The results demonstrated that that in addition to the direct toxicity effects on microbial 
cells, they also enhanced the antibacterial potential of antibiotics, by bioreductive formation of 
insoluble elemental deposits, thereby inferring with the bacterial protease machinery/proteasome. 
(Estevam et al., 2015)However, some of the previous studies speculated that selenite compounds 
exerted their antimicrobial activity by increasing oxidative stress, damaging the DNA, depleting 
the cellular thiostat (Jacob, 2011). Additionally, owing to its pro-oxidant property, Se generates 
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superoxide radicals on interactions with bacterial membranes, damaging the cellular components 
(Tran and Webster, 2013; Seko, 1997). Therefore, strong positive genotoxic effects, including 
DNA-damaging capacity and mutagenicity explained “metal toxicity” to bacteria.  
During the last decade, Se has been introduced as a potential biomolecule in the field of 
nanotechnology owing to its excellent antibacterial, antiviral, and antioxidant activity (Shakibhaie 
et al., 2015). Antibiofilm activity of biosynthesized and synthetic Se nanoparticles were 
demonstrated against several foodborne pathogens, including B. cereus, Enterococcus faecalis, S. 
Typhimurium, and S. Enteritidis (Khiralla and Deeb, 2015; Tran and Webster, 2011), and against 
drug-resistant nosocomial pathogens such as methicillin-resistant S. aureus (MRSA) (Tran and 
Webster, 2011). Investigations on the pharmacokinetics of Se after oral administration of sodium 
selenite in rats revealed an absorption rate-limiting elimination in plasma profiles. The 
bioavailability of oral sodium selenite was about 49% and the renal excretion was identified as a 
major route of Se excretion after absorption (Natsuhori, 1998). Se-methylseleno-N-acetyl-
galactosamine and trimethyl selenonium-ion were identified as the urinary excretory metabolites 
(Loeschner et al., 2014). Nevertheless, based on toxicity studies conducted in mice, the estimated 
no-observed-adverse-effect level (NOAEL) in mice for sodium selenite is 0.9 mg selenium/kg (16 
ppm sodium selenite) (Abdo, 1994), whereas in humans, sodium selenite was found safe and 
tolerable when administered up to 10.2 mg/m2 i/v (Brodin et al., 2015).  The most common adverse 
effects associated with Se toxicity in humans were fatigue, nausea, and cramps in fingers and legs, 
with no identifiable biomarkers for organ toxicity (Brodin et al., 2015). 
Phytochemicals 
Phytochemicals have been an important ingredient of traditional and herbal medicines, and 
used prophylactically and therapeutically for controlling metabolic and infectious diseases. 
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Several studies have reported a wide range of beneficial properties with phytochemicals, which 
include antiseptic, anti-inflammatory, antioxidants and antimicrobial effects (Deans and Ritchie, 
1987; Baratta et al., 1998; Alma et al., 2003). The majority of phytochemicals are secondary 
metabolites, elaborated in response to pathogen invasion or environmental stress cues. 
Consequently, phytochemicals play a critical role in plant health and defense rather than regulating 
or modulating plant physiology (Reichling, 2010). One of the main advantages of using 
phytochemicals for therapeutic purposes is that antimicrobial resistance to these natural 
antimicrobials have not been documented, apparently due to their multiple modes of action which 
would impede the selection of resistant bacteria from the exposed population (Van Wyk et al., 
2000). In light of a wide spectrum of antimicrobial effects and margin of safety and affordability, 
the majority of phytochemicals are classified as GRAS (Generally recognized as safe) compounds 
by FDA.  
Several studies have demonstrated the antimicrobial properties of phytochemicals and their 
effectiveness in controlling pathogenic and spoilage microorganisms. These natural molecules 
impede bacterial viability by degrading the cell wall, damaging cytoplasmic membrane and 
membrane proteins, causing leakage of intracellular contents, coagulating cytoplasmic proteins 
and abetting the depletion of proton motif force (Burt, 2004; Savoia, 2012; Negi, 2012). 
Modulating bacterial virulence by regulating gene transcription, protein expression, and quorum 
sensing at sub-inhibitory or sub-lethal concentrations is relatively a newer approach in the use of 
phytochemicals as anti-virulence agents (Upadhyay et al., 2015). Although, the exact target(s) for 
phytochemicals are often not well defined, based on the active ingredients present, we could 
hypothesize the interacting reactions taking place in the context of antimicrobial action. For 
instance, terpenoids and phenolics often cause membrane disruption, phenols and flavonoids 
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exhibit metal chelation, whereas coumarin and alkaloids are known to affect the bacterial genetic 
material (Cowan, 1999). Nevertheless, it is important to note that these interactions are not “all or 
none” since some membrane-disrupting compounds can also cause leakage of cellular content, 
interfere with active transport or metabolic enzymes, or can dissipate the cellular energy (Davidson 
et al., 2013).  
Flavonoids are one of the important classes of phytochemicals  distributed widely in the 
plant kingdom, and are largely incorporated in the daily diet (Cushnie, 2005; Sandhar et al., 2011; 
Romano et al., 2013). They are found in a variety of fruits, vegetables, seeds, nuts, stem, flowers 
tea, wine and even honey (Middleton and Kandaswami, 1994). Approximately, 4000 types of 
flavonoids have been reported to be present in plants (Guardia et al., 2001). They are basically 
polyphenolic compounds that contain benzopyrone moiety. The basic structure of a flavonoid is 
2-phenyl-benzo-γ-pyrane nucleus consisting of two benzene rings linked through a heterocyclic 
pyran ring (Brown, 1980). There are 14 classes of flavonoids, categorized on the basis of the 
chemical nature (Savoia, 2012). They include mainly flavonols, flavones, flavanones, isoflavone, 
catechin, anthocyanidin, and chalcones. However, in plants, they are often present as pigmented 
compounds in fruits and flowers, and chemically as O-glycosides or C-glycosides. Based on 
research, the dietary intake of flavonols and flavones was found to be 23 mg/day, among which, 
flavonol quercetin contributed the maximum of 16 mg/day (Cushnie, 2005; Heim, 2002). 
Flavonoids have been reported to exert a wide range of biological activities, including anti-
inflammatory, antilipidemic, antihyperglycemic, antiviral, hepatoprotective, gastric antiulcer, 
cardioprotective, neuroprotective, antioxidant and anticancer actions (Sandhar et al., 2011; 
Romano et al., 2013).  
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Most of the flavonoids are used as constitutive antimicrobial ingredients for centuries, and 
many studies identified different classes of flavonoids possessing antifungal, antiviral and 
antibacterial activity (Cushnie, 2005; Tapas et al., 2008; Sandhar et al., 2011; Romano et al., 2013). 
Quercetin and naringenin extracted from tribal medicinal plants were reported to be antimicrobial 
against Bacillus subtilis, Candida albicans, E. coli, S. aureus, S. epidermis and Saccharomyces 
cerevisiae (Taleb-Contin et al., 2003). Similarly, Rattanachaikunsopon and coworkers (2010) 
isolated morin-3-O-lyxoside, morin-3-O-arabinoside, quercetin, quercetin-3-O-arabinoside from 
Psidium guajava leaves and reported their bacteriostatic action against different foodborne 
bacteria, including Bacillus stearothermophilus, Brochothrix thermosphacta, E. coli, L. 
monocytogenes, Pseudomonas fluorescens, Salmonella Enteritidis, S,. aureus and V. cholerae. 
Additionally, there are literature reports on the effect of flavonoids on the binding of enterotoxins 
such as staphylococcal enterotoxin B (Benedik et al., 2014). Further, numerous studies have sought 
to elucidate the antibacterial mechanisms of different flavonoids, which include their ability to 
inhibit the cytoplasmic membrane function (Ikigai et al., 1993), deplete energy metabolism 
(Haraguchi et al., 1998) and compromise nucleic acid synthesis (Mori et al., 1987). The 
glycosylated flavonol, rutin, for example, was found to inhibit bacterial DNA gyrase.  As the 
topoisomerase IV found to be essential for bacterial cell survival, the rutin-induced topoisomerase 
IV-mediated DNA cleavage thus led to an SOS response, thereby inhibiting the growth of E. coli 
(Bernard et al., 1997).  
Rutin is chemically 3, 30, 40, 5, 7-pentahydroxyflavone-3-rhamnoglucoside, also called as 
rutoside, quercetin-3-rutinoside, and sophorin. It is a citrus flavonoid glycoside abundantly present 
in passion flower, buckwheat, tea, and apple (Harborne, 1986; Kreft et al., 1999). Similar to many 
other flavonoids, rutin also possesses a number of pharmacological activities, including 
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antioxidant, cytoprotective, vasoprotective, anticarcinogenic, neuroprotective and cardioprotective 
activities (Ganeshpurkar and Saluja, 2016). Rutin has also been studied extensively for its 
antimicrobial activity against various bacteria, virus and fungi (Arima et al., 2002; Ibrahim et al., 
2013). For instance, Choi et al (2012) demonstrated the antiviral activity against influenza 
A/WS/33 virus in mice, whereas Han (2009) used rutin to treat C. albicans associated septic 
arthritis. Antioxidant and antimicrobial activities of rutin were also identified in different food 
systems by Stojkovic´ et al (2013). Likewise, de Queiroz Pimentel and coworkers isolated rutin 
from honey and evaluated its antimicrobial activity against S. aureus, E. coli 0157: H7, Proteus 
vulgaris, Shigella sonnei and Klebsiella spp. (de Queiroz Pimentel et al., 2013). Rutin was also 
found to inhibit biofilm formation by foodborne drug-resistant E. coli and S. aureus (Al-Shabib et 
al., 2017).  
Flavonoids, in general, have minimal toxicity due to their wide distribution in edible plant 
products, and rutin demonstrated no significant carcinogenic potential in vivo (Morino et al., 1982). 
According to investigations on the pharmacokinetics and bioavailability of quercetin glycosides in 
humans, after oral administration, rutin is absorbed in the intestine and peak plasma level reaches 
~7.0 ± 2.9 hours after ingestion with a terminal elimination half-life of about 11 hours (Graefe et 
al., 2001; Andlauer et al., 2001). Rutin was found to get absorbed more slowly than other quercetin 
compounds since its gets hydrolysed by the cecal microflora (Manach et al., 1997). Rutin 
circulated in plasma in conjugated forms and its clearance is mostly renal (Choudhury et al., 1999; 
Marin et al., 2015).  In studies conducted in rodents, a high concentration of conjugates was 
maintained in plasma with a regular supply of rutin in diet (Manach et al., 1997). After oral 
ingestion of rutin, 3, 4-dihydroxyphenylacetic acid (DHPAA) was found to increasingly circulate 
in the urine of rabbits identifying HPAA as a potential metabolite of the molecule (Booth et al., 
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1956; Pashikanti et al., 2010). Meanwhile, in humans and rodents, the methylated form of rutin, 
namely isorhamnetin, was found to be the renal metabolite that was eliminated (Manach et al., 
1997; Graefe et al., 2001). 
Animal models of EHEC infection 
Several animal models have been proposed for investigating the pathogenesis of EHEC. 
Among these, some of them served as infection models, in which animals are orally inoculated 
with live EHEC in order to study the colonization effects. Meanwhile, others are injection models, 
in which they are parenterally inoculated with vertoxins intending to evaluate the effects of toxin. 
However, no animal model to date reproduces the full spectrum of clinical disease induced by 
EHEC in humans despite 30 years of research on EHEC pathogenesis (Ritchie et al., 2015; 
Mohawk and O’Brien, 2011). At present, pigs, rabbits, and mice are the three most common 
mammalian species used to study EHEC-mediated disease (Ritchie et al., 2015). Among the mouse 
infection models, germ-free and streptomycin-treated models facilitate better EHEC colonization 
by neglecting or suppressing the effects of normal enteric flora (Mohawk and O’Brien, 2011). 
Other animal species occasionally considered as model hosts of EHEC-induced disease are ferrets, 
greyhounds, gnotobiotic calves, and primates (Ritchie et al., 2013). Recently, the nematode 
Caenorhabditis elegans has been recognized as a naturally infected and genetically tractable 
invertebrate host to study EHEC infection (Ritchie et al., 2013). 
Several characteristics of C. elegans make it suitable for studying host-pathogen 
interactions. Its rapid life cycle, ease of conducting research, genetic screens, and sharing of 
conserved innate immune pathways with humans (Irazoqui et al., 2010) provide benefits in 
investigating EHEC pathogenesis. Moreover, reports indicate that intestinal cells of the nematode 
share similar anatomic features with humans (McGhee, 2007), which makes it an ideal model to 
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study infections caused by enteric pathogens. Furthermore, EHEC can colonize and induce the 
characteristic attaching and effacing lesions in the nematode gut, and shiga-like toxin 1 (Stx1) is 
identified to be a partial requirement for EHEC pathogenicity in C. elegans (Chou et al., 2013). 
All these observations suggest that EHEC exerts similar and conserved virulence mechanisms in 
C. elegans and humans. An additional advantage of using C. elegans is that the pathogenic 
bacterium under study can be substituted in place of the normal feed of the nematode (E. coli 
OP50) as the nutritional source, and the primary site of the infection will be the intestine. 
Moreover, phenotypes such as animal survival, motility, and pathogen burden can be easily and 
noninvasively examined in C. elegans (Marsh and May 2012). The nematode has also been 
identified as an efficient model to screen for novel anti-infective agents against bacterial infection. 
It has been hypothesized that these nematode-based screens would identify the efficacy of those 
antimicrobials in blocking microbial virulence, inhibiting bacterial growth and stimulating host 
immune responses (Sifri et al., 2005; Moy et al., 2006, 2009).  
In summary, EHEC is a major food-borne pathogen causing severe morbidity and mortality 
in humans. Controlling EHEC persistence in processing facilities and inactivating the pathogen in 
undercooked ground beef could reduce food-borne disease outbreaks in humans. Moreover, 
attenuating EHEC virulence would reduce the severity of infection and improve disease outcome 
in humans. This Ph.D. dissertation targets EHEC from both these aspects, and is expected to yield 
potential new strategies for reducing risks due to this pathogen to humans.  
Hypothesis 
Based on published literature and preliminary research, it is hypothesized that Se and RT 
are effective in attenuating EHEC virulence by reducing verotoxin synthesis and impeding host 
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cell receptor–toxin-mediated pathogenesis. In addition, Se is effective as an anti-biofilm agent on 
food contact surfaces and rutin increases heat sensitivity of EHEC. The specific objectives include: 
1. Investigate the effect of Se in inhibiting and inactivating EHEC biofilms on food contact 
surfaces. 
2. Investigate the effect of RT in enhancing thermal destruction of EHEC in undercooked ground 
beef.  
3. Determine the effect of Se in reducing EHEC verotoxin production and Gb3 receptor expression 
on host cells. 
4. Determine the effect of RT in reducing EHEC verotoxin production and toxin binding to Gb3 
receptor. 
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Biofilms are groups of microorganisms enclosed in a self-generated extracellular 
polysaccharide (EPS) matrix and can adhere to surfaces creating a dynamic environment to utilize 
available nutrients efficiently. Escherichia coli O157:H7 (EHEC) is a potent biofilm-forming 
foodborne pathogen and its biofilms have been identified as a source of food contamination and 
foodborne disease outbreaks. Owing to the high resistance of biofilms to most of the approved 
chemical sanitizers and disinfectants, there is an increasing interest in identifying effective 
treatments for controlling EHEC biofilms on food processing equipment and environments. 
Selenium (Se) is a naturally occurring dietary essential element with demonstrated 
antibacterial and antioxidant properties. This study investigated the effect of Se in reducing EHEC 
EPS synthesis, inhibiting biofilm formation at 37oC and 25oC on polystyrene surface, and 
inactivating mature EHEC biofilms in combination with hot water. Sterile 96-well polystyrene 
plates inoculated with EHEC (∼6.0 log CFU/well) were treated with sub-inhibitory concentrations 
(SIC) of Se, and biofilms were allowed to mature at 4oC and 25oC for 96 h.  Biofilm-associated 
bacterial population was determined by scraping and plating, whereas the extent of EPS production 
was determined using ruthenium red staining assay. Solid Surface Assay was used to study the 
effect of Se on early attachment of EHEC cells to polystyrene. The efficacy of Se in rapidly 
inactivating pre-formed, mature EHEC biofilm was investigated by treating biofilms on 
polystyrene plates with the MBC and 2XMBC of Se in combination with hot water at 80 ͦ C with 
a contact time of 0, 2 and 5 min. Furthermore, the effect of Se on EHEC biofilm architecture was 
visualized using confocal microscopy, whereas the effect of Se on EHEC biofilm genes was 
determined using real-time qPCR. Finally, the potential feasibility of coating stainless steel surface 
with Se nanoparticles to inhibit EHEC biofilm formation was studied. 
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Selenium reduced early attachment of planktonic cells, biofilm formation and EPS 
synthesis in EHEC (P < 0.05). Selenium in combination with hot water (80°C) reduced biofilm-
associated bacterial counts to undetectable levels at 5 min of exposure compared to control 
(P < 0.05). However, hot water treatment alone decreased biofilm-associated bacterial counts by 
only 1.0 log CFU/ml. RT-qPCR results revealed that Se down-regulated the transcription of critical 
genes associated with biofilm synthesis in EHEC (P < 0.05). The results collectively suggest that 
Se could potentially be used for controlling EHEC biofilms in food processing environment, but 





Enterohemorrhagic Escherichia coli O157: H7 (EHEC) is a major foodborne pathogen that 
causes a serious illness in humans, including hemorrhagic diarrhea and hemolytic uremic 
syndrome (HUS), characterized with kidney failure.  EHEC poses a significant public health 
concern owing to its ability to produce fatal food-borne infections with a low infectious dose (2–
2,000 cells) (Buchanan, 1997; Strachan et al., 2005). EHEC associated foodborne illnesses are 
estimated to cost the US economy ~ 200 million dollars annually (Hoffman et al., 2015). Although 
a variety of foods have been implicated as vehicles of infection, the majority of EHEC foodborne 
outbreaks are associated with the consumption of undercooked ground beef products (Armstrong 
et al., 1996; Hussein, 2007). Cattle serve as the principal reservoir of EHEC, excreting the 
pathogen in feces, thereby contaminating food, water, and the environment. Besides its presence 
in animal reservoirs, EHEC has the ability to persist in multiple environmental niches, including 
water and soil in the farm (Vogeleer et al., 2014).  
Biofilms are groups of microorganisms enclosed in a self-generated extracellular 
polysaccharide (EPS) matrix, and such aggregates of bacteria adhere to surfaces creating a 
dynamic environment to utilize nutrients efficiently (Donlan and Costerton, 2002). Microbial 
biofilms can be formed on any surface with an abundance of moisture and nutrients, and are found 
to be highly resistant to common disinfectants and antimicrobials (Bower et al., 1996; Srey et. al., 
2013). Biofilm formation starts with the initial attachment of planktonic bacterial cells to a surface, 
following which attached cells enter a maturation stage, where an extracellular polymeric 
substance gets secreted out and microcolonies are formed (Donlan and Costerton, 2002). The 
aggregates of these microcolonies subsequently form matured biofilms, which become 
disintegrated and dispersed to new substrates to form new biofilms (O'Toole et al., 2005). 
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Therefore, the presence of biofilms on food contact surfaces may act as a continuous source of 
food contamination, thereby constituting a food safety hazard (Cappitelli and Villa, 2014). 
The presence of EHEC biofilms in food processing environments, animal slaughterhouses 
and meat packing plants has been reported (Kumar and Anand, 1998; Aslam et al., 2004; Rivera-
Betancourt et al., 2004; Vogeleer et al., 2014). Contamination of beef carcasses with EHEC could 
occur during different stages of processing, including slaughtering, dressing, chilling or cutting 
(Bacon and Sofos, 2003; Koutsoumanis and Sofos, 2004). The ability of EHEC to form biofilms 
on different equipment surfaces has been attributed to its distribution and persistence in meat 
processing plants (Carpentier and Cerf, 1993; Dewanti and Wong, 1995; Aslam et al., 2004; 
Rivera-Betancourt et al., 2004). Furthermore, many EHEC outbreaks associated with the 
consumption of fresh produce, such as cabbage, celery, radish sprouts, lettuce, spinach, and 
tomatoes have been linked to surface colonization and persistence by the biofilm-forming bacteria 
(Beuchat 2002; Brandl 2006). Hazard Analysis and Critical Control Points (HACCP) and Good 
Manufacturing Practices (GMP) are employed in the food industry for ensuring food safety. 
However, because of potential shortcomings in clean-in-place regimens, bacteria can form 
biofilms on equipment surfaces in the production line, especially in the presence of moisture and 
nutrients (Ostrov et al., 2016). This is particularly significant since commonly used sanitizers such 
as hypochlorite and quaternary ammonium compounds are not fully effective in inactivating 
bacterial biofilms (Ostrov et al., 2016). Therefore, there is a need for controlling EHEC biofilms 
in food processing equipment and environments for reducing food contamination. 
Historically, a variety of metals has been used as antimicrobial agents. Research has 
focused on heavy metal interactions on bacterial biofilms for bioremediation of soil and sediment, 
and wastewater management (Harrison et al., 2004). Additionally, several studies have 
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investigated the antibiofilm effect of metals such as zinc, copper, gallium, silver, chromium, and 
tellurium on various bacterial species, including E. coli, Pseudomonas aeruginosa, and 
Staphylococcus aureus (Harrison et al., 2004, 2005a, 2005b; Kaneko et al., 2007). Selenium (Se) 
is a naturally occurring essential microelement recommended for daily intake by the United States 
Food and Drug Administration (US-FDA, 2003). Owing to its pro-oxidant property, Se generates 
superoxide radicals, which interact with many bacterial components, including membranes and 
nucleic acids, thereby exerting antimicrobial action (Tran, 2008; Tran et al., 2014; Seko and Imura, 
1997). Moreover, organoselenium compounds are reported to covalently attach to solid surfaces 
and catalyze oxygen radical generation, thus reducing bacterial colonization and biofilm formation 
on surfaces (Tran et al., 2012). Sodium selenite (Na2SeO3) is a commonly used dietary supplement 
containing Se, with proven antifungal and antibacterial properties (Soriano-Garcia, 2004; Kumar 
et al., 2010). In this study, the efficacy Se for inhibiting EHEC biofilm synthesis and inactivating 
mature biofilms was investigated. Further, the effect of Se on the transcription of critical biofilm-
associated genes in EHEC was determined. 
MATERIALS AND METHODS 
Bacterial Strains and Culture Conditions:  
All bacteriological media were purchased from Difco (Becton Dickinson, Sparks, MD). 
Two strains of EHEC (EDL 933, E163) were used in this study. Each strain of EHEC was cultured 
separately in 10 ml of sterile tryptic soy broth (TSB) and incubated at 37°C for 18 h. Following 
incubation, the bacteria from each culture were pelleted by centrifugation (3600 ×g for 15 min), 
washed twice and suspended in 10 ml of sterile phosphate buffered saline (PBS, pH 7.0). The 
bacterial count in each of these cultures was determined by plating 100 µl of ten-fold serial 
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dilutions on duplicate tryptic soy agar (TSA) and Sorbitol MacConkey agar (SMA) plates, 
followed by incubation at 37°C for 24 h to 48 hours.  
Determining the SIC, MIC, and MBC of Se against EHEC:  
The SIC (sub-inhibitory concentration), MIC (minimum inhibitory concentration) and 
MBC (minimum bactericidal concentration) of Se against EHEC were determined, as described 
earlier (Amalaradjou and Venkitanarayanan, 2011). Sterile 24-well polystyrene tissue culture 
plates (Costar, Corning Incorporated, Corning, NY) containing TSB (1 ml/well) were inoculated 
separately with ~ 6.0 log CFU of each EHEC separately, followed by the addition of 0 to 5 µl of 
50% stock solutions of Se (sodium selenite, Sigma-Aldrich, St. Louis, MO) with an increment of 
0.5 µl. The plates were incubated at 37oC for 24 h, and bacterial growth was determined by 
culturing on duplicate TSA and SMA plates. The highest concentration of Se that did not inhibit 
bacterial growth after 24 h of incubation as compared to control samples was selected as its SIC 
for this study, whereas the lowest concentration of Se that inhibited bacterial growth after 
incubation was taken as the MIC of the treatment. The lowest concentration of Se that reduced 
EHEC population by ~ 5.0 log CFU/ml after incubation at 37oC for 24 h was taken as the MBC.  
Biofilm Inhibition Assay on Polystyrene Surfaces: 
The efficacy of SIC of Se in inhibiting EHEC biofilm formation on polystyrene was 
investigated using a published protocol (Amalaradjou et al., 2010). Sterile 96-well polystyrene 
tissue culture plates (Costar) were inoculated with 200 µl (~ 6.0 log CFU) of overnight, PBS- 
washed EHEC cultures, followed by the addition of SIC of Se. The plates were incubated at 25°C 
or 4°C for 96 h. At 24, 48, 72, and 96 h of incubation, biofilm-associated EHEC populations were 
be enumerated by scraping and plating 100 µl volume on duplicate TSA and SMA plates and 
incubation at 37°C for 24 hours.  
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Effect of Se on EHEC Exopolysaccharide (EPS) Production: 
 The efficacy of Se in reducing EPS production in EHEC biofilms was determined by 
ruthenium red staining assay (Borucki et al., 2003). EHEC biofilms were allowed to develop in 
the presence of SIC of Se at 25°C or 4°C for 96 hours, described previously. After 24, 48 and 96 
hours of incubation, the biofilms developed were scraped and washed with PBS thrice, followed 
by the addition of 200 μl of aqueous 0.01% ruthenium red (Sigma-Aldrich) to each well and 
incubation at 25oC for 60 minutes. The optical density (450 nm) of the residual stain was then 
measured using synergy HT multi-mode microplate reader (BioTek, Winooski, VT). The amount 
of dye bound to the biofilm was determined by the formula ODBF = ODB − ODS (ODBF: optical 
density (450 nm) of biofilms; ODB: optical density (450 nm) of blanks; ODS:  optical density 
(450 nm) of the residual stain collected from sample wells). Wells without biofilms added with 
200 μl of ruthenium red stain acted as blanks (Zameer et al., 2010).  
Solid Surface Attachment Assay: 
The effect of Se on the initial attachment of EHEC cells to a solid surface was determined 
using a published method (Hay et al., 2009). Briefly, sterile 96-well polystyrene tissue culture 
plates were inoculated with 200 µl (~ 6.0 log CFU) of overnight grown EHEC cultures with or 
without SIC of Se and incubated at 37°C for 8 h. At 0, 2, 4, 6 and 8 hours of incubation, non-
adherent EHEC were washed off with PBS and 125 µl of 0.1% crystal violet (Sigma-Aldrich) was 
added to each well and incubated at 25oC for 10 min. Subsequently, crystal violet bound to the 
adherent bacterial cells was solubilized by the addition of 200 µl of 100% dimethyl sulfoxide 
(Sigma-Aldrich) and absorbance was measured at 595 nm. 
Efficacy of Se in combination with hot water for rapid inactivation of EHEC mature biofilm.  
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Sterile 96-well polystyrene tissue culture plates were inoculated with 200 µl of each EHEC 
culture (~ 6.0 log CFU) and incubated at 37°C for 96 hours without agitation. After 96 hours of 
incubation, EHEC biofilms were treated with bactericidal concentrations (MBC and 2 X MBC) of 
Se in hot water (80°C) for 0, 30 seconds, 2 minutes and 5 minutes. The biofilm-associated EHEC 
populations were enumerated as described before. When EHEC was not detected by direct plating, 
samples were tested for surviving bacterial cells by enrichment at 37°C for 24 hours, followed by 
streaking on SMA plates. 
Confocal Microscopy: 
  In situ confocal laser scanning microscopy was used to visualize the three-dimensional 
structure of EHEC biofilms treated with and without Se (Amalaradjou and Venkitanarayanan, 
2011; Narayanan et al., 2016). EHEC biofilms were formed on Lab-Tech four-chamber no. 1 
borosilicate glass coverslips (Lab-Tek, Nalge Nunc International, Rochester, NY), and treated with 
the MBC and 2 X MBC of Se in hot water (80°C) (as described in the inactivation assay). Live 
and dead cells were imaged after staining with 2.5 µM SYTO (Molecular Probes Inc., Eugene, 
OR) and 5 µM propidium iodide (Molecular probes). Samples were examined under a Leica true 
confocal scanner SP2 microscope using a water immersion lens. A krypton-argon mixed-gas laser 
with PMT2 filter served as the excitation source. 
Effect of Se on the expression of EHEC biofilm-associated genes: 
The effect of Se on the transcription of EHEC biofilm-associated genes (motB, fhD, initial 
attachment, and motility; lsrA, quorum sensing; csgD, master transcription regulator) was 
investigated by using real-time quantitative PCR (RT-qPCR) (Lee et al., 2013).  Each EHEC strain 
was grown separately with or without the SIC of Se at 37°C in TSB to mid-log phase in sterile 12 
well polystyrene plates. Total RNA was extracted using RNeasy RNA isolation kit (Qiagen, 
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Valencia, CA). Complementary DNA (cDNA) was synthesized using the I script cDNA synthesis 
kit (Biorad, CA) and used as the template for RT-qPCR. The amplification product was detected 
using SYBR Green reagents (Biorad, Hercules, CA). Relative gene expression was determined by 
the comparative critical threshold (2-∆∆Ct) value method using a 7500 Step one Real Time PCR 
system (Applied Biosystems, Carlsbad, CA), and expressed as fold change in expression relative 
to controls. Data were normalized to the endogenous control (16S rRNA) and the level of candidate 
gene expression between control samples (not exposed to Se) and treated samples (exposed to SICs 
of Se) was compared to study the effect of Se on the expression of each biofilm-associated gene. 
Gene specific primers were used based on published literature (Lee at al., 2013), and 16S rRNA 
gene was used as a housekeeping gene or endogenous control.  (Table 1). 
EHEC Biofilm Inhibition on Stainless Steel Coated with Se Nanoparticles:  
Synthesis and Substrate Preparation of Selenium Nanoparticles (SeNp):  
Selenium nanoparticles were synthesized from sodium selenite (Na2SeO3), where 
selenium in its highest oxidation state (+4) gets reduced by a mild reducing agent (L-Glutathione 
reduced) (Tran and Webster, 2013). For the synthesis, sodium selenite (≥ 98.0%, Sigma-Aldrich, 
MW = 172.94 gmol-1), reduced L-Glutathione ( ≥ 98.0%, Sigma-Aldrich, MW = 307.32 gmol-1) 
and sodium hydroxide pellets (ACS reagent, ≥ 97.0%, Sigma-Aldrich, MW = 40 gmol-1) were 
used. A volume of 10  ml of sterile deionized water and 10 ml of 100 mM reduced L-glutathione 
were added to a beaker followed by 10 ml of 25 mM of sodium selenite with continuous stirring. 
After gentle mixing, 2 ml of 0.5M sodium hydroxide was slowly added until the pH of the resultant 
reaction mixture reached ~11. Immediately following the addition of sodium hydroxide, Se 
nanoparticles synthesis started, which was visualized by a color change from a clear 
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white/transparent solution to a clear red solution indicating the formation of nanoparticles (Fig. 
8A). After the solution color turned red, the beaker was left undisturbed for another 10 minutes. 
Prior to SeNP coating, stainless steel coupons (type 304; diameter 1 cm) were degreased 
by soaking in acetone for 10 minutes, washed thoroughly with distilled water, and cleaned with 
ethanol. This was followed by rigorous rinsing of the coupons with distilled water and subsequent 
boiling in distilled water for 10 min. Finally, the coupons were autoclaved for 15 min at 121°C 
(Amalradjou and Venkitanarayanan, 2011). The pre-cleaned stainless steel coupon substrates were 
then rinsed with sterile deionized water and immersed in a beaker containing SeNP overnight. 
After SeNPs were adsorbed to the steel surface, individual coupons were taken out from the 
nanoparticle solution and washed several times with sterile deionized water to get rid of any excess 
unbound Se nanoparticles. Subsequently, the steel coupons coated with SeNP were kept in a 
heating oven (~ 100°C) for drying before using in biofilm studies. 
Biofilm Inhibition: 
Stainless steel coupons coated with or without SeNP were inoculated with ~ 6.0 log CFU 
of EHEC and biofilms were allowed to develop on the coupons for 96 hours at 25°C. At 24, 48, 
72 and 96 hours, coupons were rinsed in  sterile distilled water for 15–20 seconds, and placed in 
50-ml centrifugation tubes with ~ 3 g of glass beads and 30 ml of sterile PBS, and subjected to 
sonication (Ultrasonicator, Branson Digital Sonifier, Danbury, CT)  for 5 min at 50 W. The EHEC 
population was enumerated by serially diluting and plating the PBS suspension onto duplicate 
SMA agar plates with incubation at 37°C for 24 hours.  
Statistical analysis. The entire study was repeated three times with duplicate samples with a 
completely randomized design. Data were analyzed using the PROC GLM SAS and differences 
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between the means were compared using least significant difference) test.  Differences were 
considered significant when the P value was < 0.05. 
RESULTS: 
The SIC and MBC of Se against EHEC were 30 mM and 173 mM, respectively. Since Se 
was found to be equally effective in inhibiting and inactivating EHEC biofilms irrespective of the 
strain (P > 0.05), the results obtained with EHEC EDL 933 only are discussed in the manuscript.  
Effect of SIC of Se on EHEC Biofilm Formation on Polystyrene Plates:  
Selenium inhibited EHEC biofilm formation on polystyrene surfaces at both 25 and 4oC (P 
< 0.05). As observed in Figure 1, the SIC of Se decreased EHEC counts in biofilm by ∼ 4.0 log 
CFU/ml after 96 hours of incubation at 25°C (Figure 1A) and ~ 2.5 log CFU/ml at 4°C (Figure 
1B) compared to that in control wells, which yielded a biofilm-associated bacterial count of ∼ 8.0 
log CFU/ml at 25°C and ∼ 5.0 log CFU/ml at 4°C at the end of 96 hours.  
Effect of Se on EPS Production: 
Figure 2 shows the efficacy of Se in inhibiting EPS production in EHEC biofilms. With a 
linear positive relationship between the absorbance and EPS synthesis taken into account, higher 
absorbance values indicated greater EPS content. The EPS production associated with EHEC 
biofilms was found to be greater at 4°C (Figure 2B) than 25oC (Figure 2A) (P > 0.05). However, 
regardless of the incubation temperature, Se decreased EPS production throughout 96 hours of 
incubation (P < 0.05).  
Effect of Se on Initial Surface Attachment of EHEC: 
Since the initial attachment of planktonic cells to a surface is one of the critical steps in 
biofilm development, EHEC populations that attached to polystyrene surfaces over the first 8 hours 
of incubation in the presence and absence of Se was determined. Results revealed that adherent 
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EHEC in the presence of Se at 8 hours was ~ 84% lesser compared to that in control samples 
devoid of Se (Figure 3). This indicates that initial surface attachment of EHEC cells to polystyrene 
was significantly interfered with in the presence of Se (P < 0.05).  
Effect of Se on Pre-Formed EHEC Biofilms: 
For the biofilm inactivation assay, the efficacy of MBC (173 mM) and 2 x MBC (346 mM) 
of Se for rapidly inactivating fully formed EHEC biofilms in combination with hot water at 80oC 
was determined. As observed in Figure 4, EHEC counts in preformed biofilms were decreased to 
undetectable levels (direct plating and enrichment negative) after 5 minutes of treatment with 346 
mM Se in hot water at 80°C (P < 0.05). In the presence of 173 mM of Se, a decrease of 3.0 log 
CFU/ml in biofilm-associated bacterial population was observed at 5 minutes (P < 0.05) (Fig 4). 
However, there was no significant reduction in biofilm-associated EHEC population treated with 
hot water alone (P > 0.05).  
Confocal Microscopy: 
The confocal images concurred with the results from the biofilm inactivation assay. In 
control biofilms, a dense layer of live bacterial cells stained green by SYTO dye was observed 
(Figure 5A), whereas biofilms exposed to Se revealed patchy breaks with disrupted organization 
and dead cells stained red by propidium iodide dye. The degree of biofilm disruption was found to 
increase with Se concentration, with only dead cells (stained red)  in biofilms treated with 346 mM 
(Figure 5D) as against a mosaic of living and dead cells (stained green and red) in images from 
173 Se treatment (Figure 5C). Similarly, a mixture of dead and living cells was observed in images 
from hot water treatment alone (Figure 5B). 
Effect of Se on Genes Critical For Biofilm Formation in EHEC: 
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Real-time quantitative PCR results revealed that the SIC of Se significantly down-regulated 
the expression of the genes critical to EHEC biofilm synthesis except for motB ( P > 0.05). Among 
the three genes down-regulated, the transcription of lsr A involved in quorum sensing in EHEC 
was most down-expressed. 
Anti-biofilm Efficacy of Selenium Nanoparticles: 
As revealed by TEM, the SeNPs synthesized were in nanometer dimensional scale and 
found to be < 100 nm (Figure 7B). Results indicated that SeNP coated stainless steel coupons 
exerted an inhibitory effect on EHEC biofilm formation compared to that on uncoated steel 
surfaces (Figure 7C). Although an initial population of ~ 6.0 log CFU/ml of EHEC was inoculated 
onto control and SeNP-treated coupons, ~ 5.5 log CFU/ml of EHEC was recovered from uncoated 
coupons as against 2.0 log CFU/ml from Se-treated steel surface after 96 hours (P < 0.05).  
DISCUSSION 
Microbial biofilms are sessile bacterial aggregates with distinct architecture enclosed in a 
slimy layer of polysaccharides. This protective layer helps bacteria associated with the biofilm to 
remain resistant to the external sanitizers and disinfectants. Therefore, in this study, we evaluated 
the efficacy of Se for inhibiting biofilm formation from planktonic cells and inactivating pre-
formed EHEC biofilms on polystyrene. This was based on the assumption that the SIC of Se may 
inhibit biofilm synthesis from planktonic cells by down-regulating critical biofilm-associated 
genes, whereas bactericidal concentrations of Se will be effective in killing mature biofilms. Since 
biofilm starts when bacterial cells sense the surrounding environmental conditions to form a 
monolayer, the initial attachment of planktonic cells to a surface is critical for successful biofilm 
formation (Beloin et al., 2008; Crouzel et al., 2014). Initial bacterial adhesion to abiotic surfaces 
depends on physicochemical and electrostatic interactions between the bacterial envelope and the 
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substrate (Dunne, 2002).  Furthermore, exopolysaccharides are the functional and structural units 
of a biofilm matrix, with biofilm maturation beginning with the production of EPS. 
Exopolysaccharides give a three dimensional structure to the biofilm and protect the bacterial cells 
from disinfectants (Ghafoor et al., 2011; Lembre et al., 2012; Flemming and Wingender, 2010). 
Therefore, the effect of Se on the initial attachment of EHEC cells on polystyrene and EPS 
production was determined. The results indicated that EHEC attachment onto polystyrene at 8 
hours of incubation and EPS production were significantly interfered in the presence of Se (P < 
0.05) (Figure 2 and 3). 
In the experiments evaluating the inhibitory effect of Se on EHEC biofilm formation, it 
was observed that the SIC of the metal (30 mM) reduced biofilm-associated bacteria by ~ 4.0 log 
and ~ 2.5 log CFU/ml at 25 and 4°C, respectively, at the end of 96 hours of exposure (Figure 1 A 
and B). The decreased inhibitory effect of Se on biofilm at 4oC could be attributed to the reduced 
metabolic rate of the bacterium at this temperature compared to 25oC (Amalaradjou and 
Venkitanarayanan, 2011). 
Since it is known that metals such as zinc and manganese exert diminished antibacterial 
effect on mature biofilms due to their decreased diffusion through the biofilm architecture (Hu et 
al. 2007; Harrison et al., 2007), we used MBC and 2 X MBC of Se for killing pre-formed EHEC 
biofilms. Further, since clean in place (CIP) regimens used in food processing plant sanitation 
involve sanitizer treatments along with hot water at 80°C  for 5 to 60 min (Gibson et al., 1999), 
we determined the efficacy of sodium selenite (highly soluble in water) in hot water as a sanitizer 
treatment for rapidly inactivating EHEC biofilms. The results from the inactivation studies 
indicated that Se combined with hot water at 80oC was effective in killing EHEC biofilms in a 
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treatment time of 5 min, with 2 X MBC of the metal reducing the bacterial load to undetectable 
levels (> 6 log CFU/ml reduction) (Figure 4).   
Since the SIC of Se was used in the experiments investigating its inhibitory effect on EHEC 
biofilm, the decreased biofilm-associated EHEC populations recovered from Se-treated samples 
were not due to EHEC killing,  but rather due to an inhibitory effect of Se on the transcription of 
genes associated with biofilm synthesis in the bacterium. Therefore, RT-qPCR was performed to 
determine the effect of SIC of Se on genes involved in the various steps of biofilm formation. It 
was found that Se significantly decreased the expression of genes involved in the initial attachment 
(flhD) and quorum sensing (lsr) in EHEC (Figure 6). Moreover, the expression of CsgD, the master 
regulator of biofilm formation in E. coli was found to be down-regulated by Se (P < 0.05). 
Since surface energy and composition of the immediate environment are critical external 
factors that influence bacterial cell attachment on a substrate (Renner and Weibel, 2011), 
manipulation of these external factors could be used to reduce bacterial surface attachment. In this 
regard, re-structuring of surfaces has been investigated to alter hydrophobicity for reducing 
bacterial cell surface attachment and inhibiting biofilm formation (Renner and Weibel, 2011). For 
example, surface coating with polymers and metal nanoparticles prevented bacterial adsorption 
and biofilm formation (Renner and Weibel, 2011; Lewis and Klibanov, 2005; Tran and Webster, 
2013). Nanoparticles, known for their high surface to volume ratios allow greater interaction with 
biological molecules. Previously, Tran and Webster (2013) and Wang and Webster (2012), 
investigated the efficacy of Se nanoparticles for preventing biofilm formation on different medical 
device substrates. However, the use of nanostructured Se coating to prevent biofilm formation of 
food-borne pathogens, including EHEC on food processing surfaces has not been determined. 
Results from biofilm experiments on SeNP-coated stainless steel indicated that EHEC biofilm 
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formation was significantly reduced (~ 3.0 log CFU/ml) on the Se-treated surface as against control 
steel coupons (Figure 7C), thereby justifying follow up studies on the potential application of Se 
coating on food contact surfaces as a promising anti-biofilm treatment. Although the exact 
mechanism behind the antimicrobial property of SeNP is not known, it is hypothesized to be due 
to their ability to deplete thiol levels in bacteria. Since thiol is required for bacterial cell function, 
Se nanoparticles serve as a catalyst in oxidizing the thiol group, which in turn reduces oxygen to 
superoxide (Spallholz et al, 2001; Wang and Webster, 2012).  In addition, a coating of stainless 
steel with Se nanoparticles may alter the surface hydrophobicity, resulting in decreased bacterial 
cell surface attachment.  
In conclusion, Se was effective in inhibiting biofilm synthesis and inactivating mature 
biofilms in EHEC. Further, a coating of stainless steel with Se nanoparticles exerted significant 
anti-biofilm treatment. However, further studies are needed to determine the safety and long-term 
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Figure 1. Selenium (Se)  inhibited EHEC biofilm formation on polystyrene plates at 25° C and 4° 
C. Data represent the mean of three replicates and three experiment repetitions. Biofilm associated 
bacterial population was found decreased by 3-4 log CFU/ml in Se treated samples compared to 
control. Error bars represent standard error of the mean. *All the treatments were significantly 
different from control at P< 0.05. 
 
 
Figure 1A: Inhibition of EHEC biofilm formation at 25° C.  
 
 
Figure 1B: Inhibition of EHEC biofilm formation at 4° C. 
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Figure 2.Selenium (Se)decreased EHEC EPS production at 25° C and 4° C. Throughout the 96 h 
of incubation, EPS production significantly decreased in Se treated samples compared to control 
at both the temperature tested. Data represent the mean of three replicates and three experiment 
repetitions. Error bars represent standard error of the mean. *All the treatments are significantly 
different from control at P< 0.05. 
 
Figure 2A: Effect of Se on EHEC exopolysaccharide (EPS) production at 25° C 
 
 
Figure 2B: Effect of Se on EHEC exopolysaccharide (EPS) production at 4° C 
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Figure 3: Selenium (Se) inhibited initial solid surface attachment of EHEC. Data represent the 
mean of three replicates and three experiment repetitions. The extent of bacterial attachment to the 
solid surface was 84% less in Se-treated samples compared to control. Error bars represent 















Figure 4: Selenium (Se) inactivated pre-formed EHEC biofilm on polystyrene microtiter plates. 
Data represent the mean of three replicates and three experiment repetitions. Error bars represent 
standard error of the mean. Selenium combined with hot water at 80°C was effective in killing 
EHEC biofilms, with 2 X MBC (346 mM Se) of the metal reducing the bacterial load to 
undetectable levels (> 6 log CFU/ml reduction) *All the treatments are significantly different from 














Figure 5: Scanning confocal micrographs of EHEC biofilm inactivation.  
In control biofilms, a dense layer of live bacterial cells stained green by SYTO dye was observed 
(Figure 5A), whereas biofilms exposed to Se revealed patchy breaks with disrupted organization 
and dead cells stained red by propidium iodide dye. The degree of biofilm disruption was found to 
increase with Se concentration, with only dead cells (stained red)  in biofilms treated with 346 mM 
(Figure 5D) as against a mosaic of living and dead cells (stained green and red) in images from 
173 Se treatment (Figure 5C). Similarly, a mixture of dead and living cells was observed in images 









Figure 6: Effect of Se on expression of biofilm associated genes in EHEC. Data represent the mean 
of three replicates and two experiment repetitions. RT-qPCR results revealed that Se significantly 
decreased the expression of genes involved in the initial attachment (flhD) and quorum sensing 
(lsr) in EHEC. In addition, the expression of csgD, the master regulator of biofilm formation in E. 
coli was found to be down-regulated by Se (P < 0.05). *All the treatments are significantly different 













Figure 7: Anti-biofilm efficacy of Selenium nanoparticles. The dimension of the synthesized 
SeNps was illustrated in the TEM images (Fig 7B). Results from biofilm experiments on SeNP-
coated stainless steel indicated that EHEC biofilm formation was significantly reduced (~ 3.0 log 
CFU/ml) on the Se-treated surface as against control steel coupons (Figure 7C). Data represent the 
mean of three replicates and three experiment repetitions. Error bars represent standard error of 
the mean. *All the treatments are significantly different from control at P< 0.05. 
                                  
Figure 7A: Se nanoparticles in solution                  Figure 7B: TEM image of a nanoparticle 
 
 




Table 1: List of primers used in this study. 
 
Gene Primer 
motB Forward 5′-CAG GGG GAA GTG AAT AAG CA-3’ 
Reverse 5′-TTC TAA ACA TCG GGC GAT TC-3′ 
flhD Forward 5′-TGC ATA CCT CCG AGT TGC TG-3′ 
Reverse 5′-GCG TGT TGA GAG CAT GAT GC-3′ 
lsrA Forward 5′-AAC ATC CTG TTT GGG CTG GCA A-3′ 
Reverse 5′-AAA CAA GCG TTC GGT TTC CGC A-3′ 
csgD Forward 5′-CCG CTT GTG TCC GGT TTT-3′ 
Reverse 5′-GAG ATC GCT CGT TCG TTG TTC-3’ 
rrsG (EHEC 16s) Forward 5′-TAT TGC ACA ATG GGC GCA AG-3′ 

























Potentiating the heat inactivation of Escherichia coli O157: H7 in ground beef 
patties by rutin 
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Escherichia coli O157: H7 (EHEC) is a major foodborne pathogen largely transmitted to humans 
through the consumption of undercooked ground beef. This study investigated the efficacy of the 
food-grade, plant-derived antimicrobial, rutin (RT) with or without chitosan (CH) in enhancing 
EHEC inactivation in undercooked hamburger patties. Further, the effect of aforementioned 
treatments on beef color and lipid oxidation was analyzed. Ground beef was inoculated with a five-
strain mixture of EHEC (7.0 log CFU/g), followed by the addition of RT (0.05%, 0.1% w/w) with 
or without CH (0.01% w/w). The meat was formed into patties (25 g) and stored at 4°C for 5 days. 
On days 1, 3, and 5, the patties were cooked (65°C, medium rare) and surviving EHEC was 
enumerated. The effect of these treatments on meat color and lipid oxidation during storage was 
also determined as per American Meat Science Association guidelines. The study was repeated 
three times with duplicate samples of each treatment. RT enhanced the thermal destruction of 
EHEC, and reduced the pathogen load by at least 3.0 log CFU/g compared to control (P < 0.05). 
The combination of RT with CH was found to be more effective, and reduced EHEC by 5.0 log 
CFU/g (P < 0.05). EHEC counts in treated-uncooked patties did not decline during storage for 5 
days (P > 0.05). Moreover, patties treated with RT plus CH were more color stable with higher a∗ 
values (P < 0.05). Results suggest that the aforementioned antimicrobials could be used for 
enhancing the thermal inactivation of EHEC in undercooked patties; however, detailed sensory 







Enterohemorrhagic Escherichia coli O157: H7 (EHEC) is one of the major food-borne 
pathogens in the United States, causing an estimated 73,000 illnesses annually (Rangel et al., 
2005). EHEC infection results in hemolytic uremic syndrome (HUS), characterized by hemolytic 
anemia, thrombocytopenia, and renal injury (Bell et al., 1997). Cattle are the principal reservoir of 
E. coli O157: H7, with fecal shedding being an important source of food and environmental 
contamination (Low et al., 2005). The majority of EHEC food-borne outbreaks in the US have 
been linked to the consumption of undercooked ground beef patties (Rhee et al., 2003; WHO, 
2011), which is attributed to the thorough mixing of bacteria throughout the meat during grinding 
(Ferens and Hovde, 2011). 
The United States Department of Agriculture (USDA) has established a zero tolerance 
policy for EHEC in ground beef, and recommended that beef patties be cooked to an internal 
temperature of 71.1°C (160°F) to ensure complete pathogen inactivation (USDA, 1998). Based on 
the degree of doneness, cooked patties can be classified as rare (60°C/140°F), medium-rare 
(65°C/149°F), medium (71.1°C/160°F) or well done (77°C/170.6°F) (Marksberry et al., 1993). A 
USDA survey on hamburger cooking practices in the US indicated that 20% of the participants 
cooked patties rare or medium rare (Ralston, 2002) which could result in EHEC survival in the 
meat. In order to ascertain that the required internal temperature (71.1°C) is attained during 
cooking of ground beef patties, the USDA advised consumers to use a meat thermometer. 
However, because of the lack of homogeneity in patty composition, and temperature monitoring 
difficulties, there is the possibility that the recommended internal temperature may not be 
uniformly attained (D’Sa et al., 2000). Further, the use of thermometers for cooking beef patties 
by consumers is limited (NCBA, 1999; McCurdy et al., 2005) due to the inconvenience of the 
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procedure, consumer uncertainty, and a lack of consumer confidence in thermometer’s ability to 
ensure food safety (USDA, 1998; Research Triangle Institute [RTI], 2001; McCarty, 2008). 
According to a survey conducted by the USDA-ERS, approximately 20% of the US 
population preferred eating rare or medium-rare patties at home, restaurants and cafeteria (Ralston, 
2002). The same study revealed that at the internal cooking temperatures specified for rare and 
medium rare patties, EHEC numbers did not decline significantly compared to those cooked at 
71.1°C. Moreover, most consumers determine the doneness of beef patties by observing the color 
and texture of cooked meat. However, color is not a good indicator of doneness because ground 
beef is prone to a non-typical color change associated with cooking called premature browning 
(PMB) (Claus, 2007), where the meat appears fully cooked in spite of not having achieved a safe 
internal temperature. Thus, PMB in ground beef can lead to inadequate cooking by consumers, 
who are misled by the cooked color (Warren et al., 1996a, b), potentially allowing EHEC survival. 
Killinger et al. (2000) reported that PMB incidence averaged about 47% in ground beef purchased 
from local retail stores. When compared to steaks and roasts, ground beef is more susceptible to 
PMB because of accelerated oxidation of the meat pigment, myoglobin that occurs as a result of 
grinding. The infectious dose of EHEC in humans is low (2–2,000 cells), emphasizing that 
undercooking of beef patties should be avoided (Buchanan, 1997; Strachan et al., 2005). Therefore, 
it is important to include an antimicrobial hurdle to ensure inactivation of EHEC in ground beef 
patties unintentionally cooked to inadequate temperatures. 
Rutin (RT) is an antibacterial flavonoid obtained from buckwheat, rhubarb and berries 
(Kreft et al., 2006; Lupaşcu et al., 2008) with well-known antioxidant, anti-inflammatory and 
antimicrobial properties (Paulo et al., 2001; Sales and Resurreccion, 2014). This plant derived 
antimicrobial (PDA) is generally recognized as safe (GRAS) and approved for use in foods (FDA, 
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2007, 2010). Chitosan (CH) is a GRAS-status polymer derived from the deacetylation of chitin, a 
natural polysaccharide present as the main component of exoskeletons of crustaceans (Kumar, 
2000). CH possesses antimicrobial properties against a wide range of Gram-positive and Gram-
negative bacteria (No et al., 2002; Sagoo et al., 2002). In addition, CH is used as an antimicrobial 
carrier coating or film on foods due to its emulsification and gelation properties (Knorr, 1984; 
Jiang and Li, 2001; No et al., 2007). 
The primary objective of this study was to determine the efficacy of low concentrations of 
RT  for enhancing the inactivation of EHEC in undercooked ground beef patties (heated to 65°C, 
medium rare) in the presence or absence of CH. In addition, the effect of aforementioned 
treatments on meat color and lipid oxidation during refrigerated storage was determined. 
MATERIALS AND METHODS 
Bacterial Strains. Five EHEC strains (E6, E8, E10, E16, and E22) all originated from 
cattle were used for the study. Strains E8, E10, and E16 were isolated from meat, strain E6 from 
milk and E22 was a calf feces isolate. All the five strains were induced for resistance to nalidixic 
acid (NA, 50 μg/ml, Sigma-Aldrich, St. Louis, MO, USA) for selective enumeration (Blackburn 
and Davies, 1994). Each strain was grown separately in 10 ml tryptic soy broth (TSB; Difco, 
Becton Dickinson, Sparks, MD, USA) supplemented with NA (Fischer Scientific, Pittsburgh, PA, 
USA) at 37°C for 24 h. After three consecutive transfers, all the three cultures were washed 
separately with phosphate buffered saline (PBS, pH 7.0) and suspended in PBS. Equal volumes of 
the five cultures were then combined and pelleted by centrifugation at 3600 × g for 15 min at 4°C. 
The pellet was suspended in 10 ml of PBS and the bacterial suspension was used as the inoculum. 
The EHEC count in the inoculum was determined by serially dilution (1:10 in PBS) and plating 
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on tryptic soy agar (TSA; Difco) plates containing NA (50 μg/ml) and incubating the plates at 
37°C for 24 h. 
Preparation of Ground Beef Patties. Fresh fine ground beef (80% lean and 20% fat) was 
purchased from a local meat processor. The ground meat was separated into portions of 25 g each, 
and randomly assigned to different treatments. Each meat portion was inoculated with the five-
strain mixture of EHEC (∼7.0 log CFU/g), followed by the addition of RT (0.05%, 0.1%w/w, 
Sigma–Aldrich, MW: 610.52, soluble in DMSO and Ethanol), with or without CH (0.01%w/w, 
Sigma–Aldrich, MW: ∼1.5 KDa). CH (1%, w/v) stock solution was prepared in 1% acetic acid 
solution to dissolve RT. The ground beef was mixed thoroughly and formed into patties (25 g). 
The patties were then placed on foam trays and wrapped with oxygen-permeable fresh meat film 
(Koch Supplies, Kansas City, MO, USA) and stored at 4°C for 5 days. 
Cooking. On days 0, 1, 3, and 5 of storage, the inoculated patties were cooked separately 
in a double-sided George Foreman Lean Mean Grilling Machine (Salton Inc., Columbia, MO, 
USA) until an internal temperature of 65°C (medium rare) was reached. A standard meat 
thermometer (Acutuff Model 34 Atkins 2 mm probe meat thermometer, Koch Supplies) was used 
to monitor the internal temperature continuously. In order to ensure uniform cooking on either 
sides, the patties were turned thrice during cooking (at 30°C, at 40°C, and at 50°C). The entire 
cooking procedure was done based on a published protocol (Suman et al., 2005; Amalaradjou et 
al., 2010). In addition, a set of uncooked, refrigerated patties containing each treatment was 
included to study the effect of antimicrobials on EHEC without applying the heat treatment 
Bacterial Enumeration. Each cooked patty was immediately transferred to a sterile 
Whirlpak bag (Nasco, Fort Atkinson, WI, USA) containing 30 ml of sterile ice-cold neutralizing 
broth (Dey–Engley neutralizing broth, Sigma–Aldrich), and homogenized in a stomacher for 2 
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min at high speed. The surviving EHEC population was enumerated by spread plating 100 μl of 
serially diluted homogenate on duplicate TSA plates supplemented with NA (50 μg/ml). In 
addition, 1 ml of the meat homogenate was added to 9 ml of TSB containing NA and incubated at 
37°C for 24 h. Following incubation, the culture was streak plated onto TSA plates supplemented 
with NA (50 μg/ml) and Sorbitol MacConkey agar supplemented with 4-Methylumbelliferyl-β-D-
glucuronide (Oxoid Ltd, Lenexa, KS, USA). 
Meat Color. Instrumental color measurements were done to determine the effect of the 
antimicrobial treatments on meat color (Hunt et al., 1991, 2012; Amalaradjou et al., 2010; Suman 
et al., 2010). Using HunterLab MiniScan XE Plus colorimeter (HunterLab Associates, Reston, 
VA, USA) with illuminant A, 2.54-cm diameter aperture, and 10° standard observer, a∗ values and 
reflectance spectra from 400 to 700 nm (at 10 nm increments) were measured on patties on 0, 1, 
3, and 5 days of storage. 
Lipid Oxidation. The effect of RT with or without CH on lipid oxidation in patties was 
determined using a procedure previously described (Sinnhuber and Yu, 1958; Hunt et al., 1991, 
2012). Briefly, 0.5 g of minced portion of each ground beef patty was added with 2.5 ml of 
thiobarbituric acid (TBA; Sigma–Aldrich) stock solution (thiobarbituric acid, 15% trichloroacetic 
acid, and 0.25 N HCl) to get a dilution factor of 6. After proper mixing, the samples were heated 
in a boiling water bath for 10 min. As soon as the samples from the control patty (without 
treatments) turned pink, the samples were immediately washed in tap water to cool down. The 
absorbance spectra of the clear supernatant obtained by centrifuging the cooled samples at 5,000 
× g for 10 min was measured at 532 nm against a blank containing reagents alone (without meat). 
The thiobarbituric acid reactive substances (TBARS) value in ppm for each sample was 
determined separately using the equation: TBARS value (ppm) = sample A532 × 2.77. 
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Statistical analysis. The inactivation study was a split plot with completely randomized 
design. Each batch of ground beef was divided into 120 patties of 25 g each. The patties were 
randomly assigned to 1 of 20 of the treatments∗storage time combination effects. Each patty served 
as an experimental unit and the entire study repeated three times with duplicate samples. The data 
were analyzed using GLIMMIX procedure of SAS 9.4 and significance was tested at P < 0.05. 
Similar analysis was done for the TBARS estimation. The a∗ values were analyzed as repeated 
measures using proc mixed procedure, and the experimental design was a randomized complete 
block design. The significance was tested at P < 0.05. 
 RESULTS  
The effect of RT with or without CH in potentiating the thermal inactivation of EHEC in 
undercooked ground beef patties is depicted in Figure 1. There was no decline in EHEC counts 
irrespective of the treatments throughout the refrigerated storage in uncooked patties, and ∼6.5 log 
CFU/g of the pathogen was recovered from patties at the end of storage period (P > 0.05) (Figure 
1A). However, when the patties were cooked to 65°C, the EHEC population was decreased by 
∼1.5 to 2.0 log CFU/g in untreated control patties. On the other hand, both tested concentrations 
of RT in combination with CH decreased EHEC counts by 2–3.0 log CFU/g on days 0 and 1, with 
>5.0 log CFU/g reduction in bacterial counts on days 3 and 5 of storage (enrichment negative; P 
< 0.05) (Figure 1B).  
The instrumental color measurements for redness of meat (a∗ values) are shown in Table 
1. As expected, the red color of control and treated patties gradually decreased over time during 
storage. The patties treated with RT (0.1 and 0.05%) plus CH displayed greater a∗ values on day 
3 of storage compared to control patties (P < 0.05). The formation of TBARS in beef patties was 
determined on days 0, 1, 3, and 5 of storage. Although TBARS increased progressively in patties 
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during storage (P < 0.05), no significant difference in lipid oxidation was observed between the 
treatments on any day of storage (P > 0.05) (Figure 2). 
DISCUSSION 
This study investigated the effect of the food-grade plant-derived antimicrobial, RT in 
enhancing the thermal inactivation of EHEC in undercooked ground beef patties in the presence 
and absence of CH. CH, a known emulsifier, was primarily used for the uniform distribution of 
the antimicrobial in meat. It was observed that RT alone or in combination with CH did not exert 
any antimicrobial effect on EHEC in uncooked refrigerated ground beef patties (Figure 1A). 
However, when the patties were heated to an internal temperature of 65°C,  RT in combination 
with CH brought about significant reductions in EHEC counts throughout the storage period (P < 
0.05) when compared to control and patties containing RT or CH alone. These results indicated 
that the combination of RT with CH and heat had a greater lethality on EHEC in beef patties than 
RT or heat alone. The increased heat destruction of EHEC in patties containing the antimicrobial 
could be attributed to their pronounced deleterious effects on bacterial cell membrane leading to 
the loss of intracellular contents and destruction of the cells. In addition, heat-induced damage of 
bacterial plasma membrane may have potentially allowed rapid accumulation of the antimicrobial 
within the cells, thereby resulting in an enhanced bactericidal effect. For example, Shibasaki and 
Kato (1978) observed that heating causes bacterial plasma membrane to become more fluid in 
nature, thereby increasing the antimicrobial activity of lipid-soluble small molecules. 
Antimicrobial flavonoids, including rutin have been reported to act on lipid bilayers of bacteria 
and believed to modify the physicochemical properties of the cell membranes (Tsuchiya, 2015). 
They are also known to interact with functional protein systems of the cell (Koval’skii et al., 2014; 
Tsuchiya, 2015). Similarly, several studies showed the deleterious effect of RT on bacterial 
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membrane, which includes oxidative damage to the cell membrane, loss in membrane integrity 
and morphology (Bajpai et al., 2014; Subramanian et al., 2014; Taylor et al., 2014). 
It was also observed in the study that CH by itself did not result in a significant reduction 
in EHEC counts (P > 0.05), except in patties that were cooked after 5 days of refrigerated storage 
(Figures 1B,). This was expected since the concentration of CH used in the study (0.01% w/w) 
was much below the antimicrobial concentration (0.5–1%) reported in the literature (Darmadji and 
Izumimoto, 1994a, b). However, the combination of RT with CH increased the thermal destruction 
of EHEC, which could be attributed to the improved solubility and distribution of the RT in the 
presence of the CH, which is a potent emulsifier (Schulz et al., 1998; Klinkesorn, 2013) and 
solubilizer (Zerrouk et al., 2004; Shete et al., 2015). In addition, synergistic antimicrobial effects 
between CH and a variety of antimicrobials, including essential oils (Wang et al., 2011) have been 
observed, and this could have contributed to the enhanced bacterial killing in cooked patties 
containing RT with CH. Previously, two plant-derived compounds, namely carvacrol and trans-
cinnamaldehyde were found to enhance the thermal destruction of EHEC in ground beef (Juneja 
and Friedman, 2008), where addition of both compounds in beef sensitized the pathogen to the 
lethal effect of heat, as evident from the significantly lower thermal destruction times of the 
pathogen in the treated samples. Similarly Amalaradjou et al. (2010) reported that addition of 
trans-cinnamaldehyde (0.15, and 0.3%) significantly reduced EHEC counts in ground beef cooked 
to an internal temperature of 60 or 65°C compared to untreated patties cooked to the same 
temperatures. Yet another study found that incorporation of apple skin and tea leaf powders at 3% 
level in ground beef decreased the heat resistance of EHEC in Sous-wide cooked ground beef 
(Juneja et al., 2009). 
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Since the attractive red color of meat is the primary yardstick by which consumer 
purchasing decisions of beef and beef products are made (Mancini and Hunt, 2005), we determined 
the effect of RT and CH on the color of uncooked beef patties during refrigerated storage. The 
results from meat color analysis revealed that none of the treatments adversely affected meat color 
compared to control patties. Further, patties containing RT and CH demonstrated a greater redness 
on days 3 and 5 of storage compared to control patties (P < 0.05). Previous studies have revealed 
that CH at 1% increased the redness and color stability of frozen beef patties and pork sausages 
(Lin and Chao, 2001; Georgantelis et al., 2007a). However, in this study a much lower 
concentration of 0.01% (w/w) was used and the color of patties containing only CH was not 
significantly greater than that of control samples. Moreover, the aforementioned researchers 
observed an elevated pH in CH added meat in their studies, and the increased meat pH may have 
minimized myoglobin oxidation and surface discoloration, thereby maintaining the meat color 
stability (Suman et al., 2010). However, we did not observe any significant change in the pH of 
meat irrespective of the treatments throughout the study. Therefore the mechanism behind the 
increased redness in patties with RT in combination with CH needs to be investigated. 
A primary cause for quality deterioration of meat during storage is lipid oxidation, which 
adversely affects color, flavor, texture and nutritional value of meat. Previous studies have shown 
that plant antimicrobials such as trans-cinnamaldehyde and rosemary oil decreased lipid oxidation 
in beef patties and pork sausages (Georgantelis et al., 2007b; Amalaradjou et al., 2010). In addition, 
CH at doses ranging from 0.2 to 1% has been documented for its ability to minimize lipid oxidation 
in meat. However, we did not observe any protective effect of RT or CH in reducing lipid oxidation 
in refrigerated beef patties, and the amount of TBARS was not different among patties throughout 
the storage period (P > 0.05). 
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Results of this study indicated that RT in the presence of CH significantly increased the 
heat inactivation of EHEC in undercooked ground beef patties without adversely affecting meat 
color and lipid oxidation. Therefore, this natural antimicrobial could be added to ground beef for 
improving the microbiological safety of undercooked beef. However, organoleptic studies are 
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Fig 1.A. Effect of Rutin (RT) with or without Chitosan (CH) on EHEC in uncooked ground beef 
patties stored at 4°C for 5 days. Fig 1.B. Effect of RT with or without CH on EHEC in ground beef 
patties stored at 4°C for 5 days and cooked to an internal temperature of 65°C. # - Negative by 
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Fig 2. Effect of Rutin (RT) with or without Chitosan (CH) on lipid oxidation in ground beef patties 
stored at 4°C for 5 days. Higher values of TBARS denote more lipid oxidation. # - Negative by 














Table 1. Effect of RT with or without CH on meat color in ground beef patties stored at 4°C for 5 
days. Increased a* value indicated increased redness of meat and means with same letters are not 
significant down each column. 
 
Treatment a* value + SE 
Control 
CH 
Day 0 Day 1 Day 3 Day 5 
29.81 + 0.84ab 25.23 + 0.71bc 17.32 + 0.62f 12.08 + 0.95bc 
30.26 + 0.94ab 26.67 + 0.59ab 21.72 + 0.54abc 12.35 + 0.92bc 
CH + RT 0.1 29.79 + 0.94ab 26.13 + 0.41b 21.54 + 0.37abcd 12.04 + 0.84bc 
CH + RT 0.05 29.87 + 1.27ab 26.06 + 0.44b 20.95 + 0.67bcde 13.57 + 0.95bc 
RT 0.1 29.84 + 0.82ab 28.24 + 0.26bc 20.01 + 0.96cde 15.23 + 0.93ab 





























Selenium reduces Enterohemorrhagic Escherichia coli O157: H7 verotoxin 
production and Gb3 receptor expression on host cells 
 

















Aim: This study investigated the efficacy of selenium (Se) in reducing Escherichia coli O157: H7 
verotoxin production and toxin gene expression. Additionally, the effect of Se on 
globotriaosylceramide (Gb3) receptor in human lymphoma cells was determined.  
Methods: The effect of Se on verotoxin synthesis was determined by standard ELISA, whereas its 
effect on Gb3 receptor was determined by flow cytometry and real-time quantitative PCR. Results 
& conclusions: Se reduced extracellular and intracellular verotoxin concentration by 40–60% and 
80–90%, respectively (p < 0.05), and downregulated verotoxin genes (p < 0.05). Se reduced Gb3 
receptor synthesis in lymphoma cells, and real-time quantitative PCR data revealed a significant 
downregulation of LacCer synthase gene (GalT2) involved in Gb3 synthesis. Further studies are 
warranted to validate these results in an appropriate animal model.  

















Shiga toxin producing (STEC) or verotoxin producing Escherichia coli (VTEC) poses a 
significant public health concern owing to its ability to produce fatal food-borne infections with a 
low infectious dose. Among the various VTEC serotypes, Enterohemorrhagic Escherichia coli 
O157: H7 (EHEC) is a major food-borne pathogen in the United States, and is estimated to cost 
the US economy ~ one billion dollars annually [1]. Cattle are the principal reservoir of EHEC, 
with fecal shedding of the pathogen being an important source of food and environmental 
contamination [2]. The pathogenesis of EHEC infection in humans is chiefly mediated by 
verotoxins, and is characterized by life threatening conditions such as hemorrhagic colitis (HC) 
and hemolytic uremic syndrome (HUS) [3]. EHEC produces verotoxin 1 and/or verotoxin 2, which 
are encoded by stx1 and stx2, respectively. Verotoxins belong to AB5 toxin family with A and B 
subunits. The pentameric B subunit binds to the host cell surface receptor, globotriaosylceramide 
(Gb3), whereas the A subunit enters the cells by endocytosis, arrests protein synthesis and causes 
apoptosis of cells [4, 5]. The total verotoxin produced by EHEC includes two components, namely 
extracellular and intracellular. The extracellular verotoxin component is released into the 
environment, whereas the intracellular portion is accumulated in the bacterial cells, and is released 
when bacterial cells are lysed [6, 7, 8].   
The use of antibiotics for treating EHEC infection is contraindicated since they induce the 
phage lytic cycle thereby augmenting the expression of stx genes encoded within the prophage 
genome [9, 10]. Neely and Friedman (11) showed that the activation of this phage lytic cycle 
resulted in increased Stx production in EHEC. 
Thus, there is a need for alternate strategies for controlling EHEC infection in humans. 
Potential novel approaches for treating EHEC infections in humans include those targeted against 
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the verotoxins, toxin receptor and their interaction, thereby reducing the cellular uptake of toxins 
and downstream pathology [12, 13, 14].  
The usage of metals as antimicrobial agents can be traced back to historical periods, with 
their application in human medicine and agriculture gradually decreasing after the discovery of 
antibiotics. However, due to the emergence of multidrug resistant pathogens and shortage of new 
antibiotics, the use of antimicrobial metals is undergoing a period of resurgence [15].  Many 
transition metals and metalloids such as copper, silver and gallium have been reported as effective 
antimicrobials and anti-biofilm agents against E. coli, Salmonella, Pseudomonas aeruginosa and 
Staphylococcus aureus [15, 16, 17, 18]. In addition, the efficacy of zinc in attenuating the virulence 
of EHEC both in vitro and in vivo was reported [19]. Similarly, manganese was found to block 
intracellular trafficking of shiga toxin, and protect mice when challenged with the toxin [20]. 
Selenium (Se) is a naturally occurring essential microelement recommended for daily 
intake by the United States Food and Drug Administration.  Selenium is present in a wide variety 
of foods, and is available as a dietary supplement. In humans, Se is an essential cofactor in 
selenoproteins, which play structural and enzymatic functions in many biological processes in the 
body, including reproduction, DNA synthesis, immunity and antioxidant defense [21, 22]. The 
daily average intake of Se in the United States ranges from 70 to 100 µg [23], with a recommended 
dietary allowance of 55 µg and tolerable upper intake level of 400 µg in adults [24].  Selenium and 
its compounds have been used in anti-cancer treatment, and as a potential orthopedic implant [25, 
26]. Sodium selenite (Na2SeO3) is a commonly used dietary supplement containing Se, with 
proven antifungal and antibacterial properties [27, 28].  
This study investigated the efficacy of sub-inhibitory concentration (SIC; highest 
concentration that is neither bactericidal nor bacteriostatic) of Se in reducing EHEC verotoxin 
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production and toxin gene expression. In addition, the effect of Se on verotoxin binding to Gb3, 
and the expression of Gb3 receptor in human lymphoma cells was determined. 
2. Materials and methods 
2.1.Bacterial strains and culture conditions 
All bacteriological media used in this study were purchased from Difco (Becton Dickinson, 
Sparks, MD).  Three strains of EHEC, namely ATCC 43895 (EDL 933), E163 (meat isolate) and 
E137 (salami isolate) were used in this study. Each strain was cultured separately in 10 ml of sterile 
tryptic soy broth (TSB, Sigma Aldrich, St. Louis, MO) in 15 ml screw-cap tubes, and incubated at 
37°C for 18 h. Following incubation, bacteria from each culture were pelleted by centrifugation 
(3,600 ×g for 15 min), washed twice and suspended in 10 ml of sterile phosphate buffered saline 
(PBS, pH 7.0). The bacterial count in each of the three cultures was determined by plating 100 µl 
of ten-fold serial dilutions of the culture on duplicate tryptic soy agar (TSA, Sigma Aldrich) and 
Sorbitol MacConkey agar (SMA, Sigma Aldrich) plates, followed by incubation at 37°C for 24 h.  
2.2.Sub-inhibitory concentration of selenium 
The SIC of Se was determined as previously described [29]. Sterile 24-well polystyrene 
tissue culture plates (Costar, Corning Incorporated, Corning, NY) containing 2 ml of TSB per well 
were inoculated separately with ~ 6 log10 CFU/ml of each EHEC culture, and 5–50 µl of a 50% 
(w/v) stock solution of sodium selenite (99% purity, Sigma-Aldrich) with an increment of 5 µl was 
added to each well. The plates were incubated at 37°C for 24 h, and bacterial growth was monitored 
by plating on TSA and SMA plates. The highest concentration of Se that did not inhibit bacterial 
growth after 24 h of incubation was selected as the SIC for the study.  
2.3.Determination of verotoxin concentration  
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The verotoxin produced by each EHEC strain was quantified by enzyme-linked 
immunosorbent assay (ELISA) using the Premier EHEC test (Meridian Bioscience, Cincinnati, 
OH), as described previously [6, 30]. Briefly, TSB containing the SIC of Se was separately 
inoculated with each EHEC strain (~6.0 log CFU/ml), and incubated at 37oC for 24 h. EHEC 
cultured in the absence of Se was included as control. After incubation, the bacterial cells were 
pelleted by centrifugation at 3,800× g for 15 min, and the culture supernatant and cell pellets were 
separated. The cell pellets were washed three times with PBS. The final washed pellet was 
resuspended in Tris-EDTA lysis buffer, and the cell membranes were disrupted using an 
ultrasonicator (Branson Digital Sonifier, Danbury, CT) at 50 W for 1 min. The extracellular and 
intracellular verotoxin concentrations were estimated in cell-free culture supernatant and cell 
lysate at both 0 and 24 h of incubation, respectively using the aforementioned ELISA kit. A 
standard curve of optical density at 450 nm versus known standard verotoxin (BEI resources, 
Manassas, VA) concentration was used to determine the unknown concentration of verotoxin in 
control and Se treated samples [6]. 
2.4.Toxin gene expression using real-time quantitative PCR (RT-qPCR) 
The effect of Se on the expression of genes encoding verotoxins (stx1 and stx2) was 
investigated using RT-qPCR, as described previously [31]. Each EHEC strain was grown 
overnight in TSB at 37°C with or without the SIC of Se, and total RNA was extracted using an 
RNeasy RNA isolation kit (Qiagen, Valencia, CA). The complementary DNA (cDNA) synthesized 
using the Iscript cDNA synthesis kit (Biorad, Hercules, CA) was used as the template for RT-
qPCR. SYBR green reagents (Applied Biosystems, Inc., CA) were used to detect the amplification 
products. RT-qPCR analysis of the verotoxin genes was performed using published primers [31], 
and normalized against 16S rRNA gene expression. Twenty-five microliter reactions were 
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performed in duplicate using iTaq SYBR RT-PCR (Bio-Rad) and repeated three times. The 
relative fold change in gene expression was calculated using the 2−ΔΔCt method [32].     
2.5.Flow cytometry 
 The effect of Se on the surface expression of Gb3 receptor protein in the Ramos cell line 
was studied using flow cytometry [33, 34, 35, 36].  Ramos cells (human Burkitt’s lymphoma; 
ATCC CRL-1596) were maintained in Roswell Park Memorial Institute medium (RPMI, Gibco, 
Invitrogen) containing 20% FBS at 37°C under 5% CO2.  The cells (~1 x 10
4 per well) were seeded 
onto a 6-well plate, and allowed to grow overnight at 37°C in the presence of 5% CO2. The cells 
were then treated with the SIC of Se for 1 h, sedimented by centrifugation at 300 x g for 10 min 
and washed with fluorescence activated cell sorting (FACS) buffer (PBS containing 0.1% fetal 
bovine serum and 0.01% sodium azide). The cells were subsequently resuspended in FACS buffer 
and labeled with FITC-conjugated mouse anti-human CD77/Gb3 antibody (BD Bioscience, San 
Jose, CA) for 30 min on ice. Unlabeled control wells (cells neither treated with Se nor incubated 
with antibody), labeled control wells (cells not treated with Se, but labeled with antibody) and 
isotype control wells (cells not treated with SIC, but labeled with FITC mouse IgM ĸ (BD 
Bioscience) were included. Isotype controls were used to confirm the primary antibody specificity 
and determine any non-specific reactivity of antibody with the cells [37]. After labeling, cells were 
washed twice with FACS buffer and analyzed by flow cytometry using a BD FACS-Calibur flow 
cytometer. The mean fluorescence intensity was calculated for all the samples [37, 38].  
In addition, the recovery of Gb3 expression on the Se-treated cells after removing the Se 
pressure was determined.  As previously mentioned, the cells (~1 x 104 per well) were seeded onto 
a 6-well plate, and allowed to grow overnight at 37°C in the presence of 5% CO2.  The cells were 
then treated with the SIC of Se for 1 h, pelleted by centrifugation at 300 x g, and washed 5 times 
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with FACS buffer. The cells were seeded onto 6 well plates, allowed to grow overnight, and 
analyzed for Gb3 expression by flow cytometry. 
2.6.Effect of selenium on the expression of Gb3 synthesis genes 
Ramos cells were seeded onto a 6-well plate, and allowed to grow overnight, as described 
previously. The cells were treated with the SIC of Se for 1 h, following which total RNA was 
extracted using TRIzol reagent (Ambion, NY) –Chloroform (Sigma Aldrich) followed by RNeasy 
RNA isolation kit (Qiagen).  RT-qPCR was performed to analyze the expression of genes involved 
in the synthesis of Gb3. The primers used for the amplification of Gb3 synthesis genes are listed 
in Table 1. The gene actB was used as endogenous control, and the level of gene expression in Se-
treated samples was compared to untreated control samples. 
2.7.Effect of Se on verotoxin binding to Gb3 receptor 
2.8.1. Isolation and quantification of Gb3 
The Gb3 receptor was isolated from Vero cells as described previously [39].  Vero cells 
(CCL-81, ATCC) were grown in Dulbecco's modified Eagle’s medium (DMEM, Gibco, 
Invitrogen) containing 20% FBS in six well polystyrene plates, and the growth was arrested at 
confluence by transferring the cells to serum deficit media. Vero cells were stimulated with the 
inflammatory factor, TNFἁ (100U/ml; Sigma Aldrich) for 24 h followed by the extraction of total 
cellular lipids.  The cells were washed with ice cold PBS (pH 7), scraped off the plates and 
centrifuged at 500 x g for 10 min. The cell pellet was then lysed using an ultrasonicator at 50 W 
for 5 min. Subsequently, cells were extracted in 1ml of chloroform: methanol: water solvent 
(5:10:3) three times, and dried under nitrogen gas. The total dried lipid was suspended in 2:1 
chloroform: methanol, and separated on silica gel thin layer chromatography plates (10 x 20 cm, 
Sigma-Aldrich) by ascending chromatography in chloroform: methanol: water (65:35:8) solvent 
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system. The lipid content on silica plates was then visualized with iodine vapor. The Gb3 standard 
(Ceramide Trihexosides Gb3, Matreya LLC, PA) was run at different concentrations (10 to 40 µg) 
on TLC plates to identify the glycolipid of interest, and determine the approximate amount of Gb3 
extracted from the cells. Additionally, a standard curve of optical density at 490 nm versus Gb3 
concentration (µg/ml) was used to determine the unknown concentration of the Gb3 extracted from 
the cells.  
The effect of Se on the binding of verotoxin to the Gb3 receptor was determined according 
to a published protocol [40]. The extracted Gb3 was retrieved from the TLC plate and dissolved 
in 2:1 chloroform: methanol solvent. Polystyrene microdilution plates (Fisher Scientific, Pittsburg, 
PA) were inoculated with Gb3 (36 µg/ml), left uncovered for 4 h at room temperature for the 
evaporation of the diluent, and subsequently washed with Tween 20-PBS buffer. Verotoxin 
extracted from an overnight culture of EHEC EDL 933 was added to the plates (50 ng/well), and 
allowed to bind to the receptor with or without the SIC of Se at 37°C for 1 h.  Following this, 
mouse anti-human CD77/Gb3 antibody (BD Bioscience) was added to the wells at 1:1000 dilution, 
and allowed to bind to Gb3 for 1 h at 37°C. Subsequently after washing with Tween-PBS, 
peroxidase conjugated rabbit anti-mouse immunoglobulin G (Promega, Madison, WI) was added 
and incubated at 37°C for another hour. The substrate orthophenyldiamine (0.4 mg/ml, Sigma-
Aldrich)-0.1% H2O2 in citrate-phosphate buffer (25 mM citrate, 50 mM phosphate, pH 5) was then 
allowed to react with the available enzyme peroxidase in the well for 15 min at room temperature 
following the washing step. The supernatants from the wells were transferred to new plates after 
incubation and the absorbance was measured at 490 nm. Wells with 0.1% BSA in 0.05% Tween 
20-PBS (diluent in which samples were diluted) instead of the sample served as negative controls.  
3. Statistical analysis 
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  All the experiments had duplicate samples for each treatment and control, and were 
replicated three times. The data were analyzed using a generalized linear model of proc genmod 
procedure of SAS 9.3 version (SAS institute, Cary, NC).  The differences between the means were 
compared using least significant difference (LSD) test and were found to be significant compared 
to control when  P<0.05.  
4. Results 
4.1.Determination of SIC of selenium 
The highest concentration of Se that did not inhibit EHEC growth when compared to control 
was 30 mM (0.5% w/v). The average initial EHEC count in Se-treated and control samples was ~ 
5 log CFU/ml. After 24 h of incubation at 37oC, ~ 8.5 log CFU/ml of EHEC was recovered from 
control and treated samples, thereby confirming that the aforementioned Se concentration was not 
inhibitory to bacterial growth (data not shown).  
4.2.Effect of selenium on verotoxin production and toxin gene expression 
      Selenium reduced both extracellular and intracellular verotoxin concentrations in all three 
EHEC strains (P<0.05) (Fig. 1 and 2). At 0 hour of incubation, the extracellular verotoxin 
concentration in both treatments and control was found to be ~ 4 to 6 ng/ml, irrespective of the 
strains, whereas the intracellular verotoxin concentration was under the detection limit (< 1 ng/ml). 
However, by the end of 24 h of incubation, compared to control (436 ng/ml) the extracellular 
verotoxin concentration in the presence of Se was decreased by 200 – 300 ng/ml (40-60%) 
(P<0.05) (Fig. 1). Similarly, the intracellular verotoxin concentration in Se-treated EHEC was 
reduced by 80-90% after 24 h of incubation (P<0.05) (Fig. 2). The magnitude of extracellular and 
intracellular verotoxin production was found to be strain specific. Among the three different 
strains, EDL 933 produced the highest amount of extracellular and intracellular toxins. Concurring 
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with the ELISA results, RT-qPCR data revealed that Se down-regulated both stx1 and/or stx2 
expression in all the three strains of EHEC (P<0.05) (Fig. 3). 
4.3.Effect of selenium on Gb3 receptor and Gb3 synthesis genes in Ramos cells  
The cell surface expression of Gb3 was determined by measuring the mean fluorescence 
intensity of gated population of live cells using flow cytometry. Live cell population as determined 
by side scatter-forward scatter gate (confirmed with propidium iodide staining) were analyzed. As 
shown in Table 2, the mean fluorescence of cells treated with Se was decreased by ~ 80% 
(observed a mean fluorescence of 10) compared to control cells (observed mean fluorescence of 
45), thereby suggesting the inhibitory effect of the Se on Gb3 receptor expression. Histograms 
showing Gb3 receptor fluorescence intensity of representative samples of unlabeled, labeled, Se 
treated cells and isotype control are shown in Fig 4.  As discussed above, there was approximately 
a log shift in the fluorescence intensity in Se-treated samples compared to the labeled control. This 
was further supported by RT-qPCR results, which indicated that Se down-regulated the expression 
of LacCer synthase gene (GALT2) involved in Gb3 synthesis (P < 0.05) (Fig. 5). In addition, Se-
treated cells were found to regain 75% of their original Gb3 expression following the removal of 
the treatment pressure (data not shown).  
4.4.Effect of Se on verotoxin binding to Gb3 receptor 
 
Gb3 receptor was extracted and the concentration was estimated from a standard curve 
generated using various concentrations of pure Gb3 standard. The average yield of Gb3 was found 
to be ~ 36 µg/ml (Fig 6A). The extracted Gb3 was then used to determine the effect of Se on toxin 
binding to the receptor. As shown in Fig. 6B, when verotoxin alone was added to the wells coated 
with Gb3, the absorbance decreased to 56% compared to control, indicating a decreased free Gb3 
availability due to active binding of toxin to the receptor. However, the toxin binding to the 
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receptor was found to be interfered to some extent in the presence of Se, where a Gb3 availability 
(83%) was observed compared to wells added with only verotoxins. This suggested that a greater 
concentration of free Gb3 was available for the antibody to bind when toxin was added with Se. 
However, the difference in Gb3 availability observed between wells containing toxin and those 
with toxin and Se was not significant (P> 0.05). Further, selenium by itself did not affect the 
antibody binding to the receptor compared to control wells (P>0.05). 
5. Discussion 
Despite being a bacterial infection, the current treatment strategies against EHEC in 
humans are limited, and do not include the use of antibiotics. As mentioned previously, this is 
because of the fact that antibiotic usage has been linked to enhanced risk of systemic complications 
such as acute renal failure [10] and elevated mortality in patients [9], due to increased verotoxin 
release from EHEC lysis [9, 10]. In addition, antibiotics can inhibit the growth of normal gut flora, 
leading to EHEC overgrowth [9]. Moreover, no effective vaccine is available against EHEC in 
humans [41, 42, 43]. Thus, there is a critical need for identifying alternate interventions for 
controlling EHEC infection in humans. 
A relatively new strategy which is being increasingly investigated for combating infectious 
diseases involves targeting microbial virulence rather than growth, where a pathogen’s specific 
mechanisms critical for causing infection or disease symptoms in hosts are inhibited [44, 45]. Since 
anti-virulence agents are neither bacteriostatic nor bactericidal, they exert a reduced selection 
pressure for the development of bacterial drug resistance [46, 47, 48], and are minimally 
deleterious on the host gut microflora.  
We observed that the SIC of Se neither inhibited EHEC growth nor killed the bacterium, but 
significantly inhibited both extracellular and intracellular verotoxin. The RT-qPCR results also 
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concurred with the aforementioned findings, where Se was found to down-regulate the expression 
of stx1 and stx2 in EHEC.  
As verotoxins are the key virulence factors that cause HUS, therapeutic interventions which 
can impede toxin binding, uptake, or receptor function are potential approaches for the treatment 
of EHEC infections [12, 13]. Moreover, Gb3 is considered as the only functional receptor for 
verotoxins in most mammals, with the cell surface expression of Gb3 being a prerequisite for toxin 
sensitivity [49, 50, 51, 52, 53, 54], and toxin-induced pathology in the host.  Further, inhibitors of 
Gb3 synthesis enzymes have been shown to reduce host cell sensitivity to verotoxin [55, 56]. 
Several studies have been conducted to identify compounds that could reduce Gb3 synthesis or 
binding to the toxin in order to prevent toxin receptor interaction. One such compound is C-9, 
which was found to inhibit the conversion of ceramide to glucosylceramide during Gb3 synthesis 
in renal tubular epithelial cells [57]. The renal tubular epithelial cells pretreated with C-9 expressed 
reduced levels of Gb3, thereby demonstrating decreased sensitivity to verotoxin type 2.  
In this study, to determine the effect of Se on the receptor expression, we used Ramos cells, 
which are known to over express Gb3 receptor. Ramos cells have been extensively used for 
studying physico-chemical characteristics of Gb3 receptor [34, 35, 36]. The level of Gb3 
expression has been reported to be high in these tumor cells which were found to be much more 
sensitive to verotoxins compared to normal renal and intestinal cells [54, 56].   
Flow cytometry is a fluorescence-based technique commonly used to analyze cells for 
extracellular and intracellular protein expression, and it provides information on the proportion of 
cells expressing a targeted receptor and the relative number of receptors expressed by a single or 
population of cells [56]. Using fluorochromes conjugated to a specific antibody that can recognize 
the protein of interest, the surface expression of receptors can be determined [58, 59].  Therefore, 
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flow cytometry was used for the quantitative analysis of the cell surface expression of Gb3 on 
Ramos cells. As shown in the results (Table 2 and Fig. 4), the mean fluorescence data indicated 
that Gb3 expression on Se-treated cells was significantly reduced in comparison to that in the 
controls (P < 0.05). These results are supported by RT-qPCR data, which revealed a significant 
down-regulation in the expression of GALT2 gene involved in Gb3 synthesis [60].  
Furthermore, we investigated the effect of Se on reducing verotoxin binding to Gb3 receptor 
using an ex vivo Gb3 binding assay. Although the results showed a relative decrease in toxin 
binding to the receptor in the presence of Se, the reduction was not significantly different from 
that of the toxin control (P > 0.05). These results indicate that the potential therapeutic effect of Se 
is mainly mediated by decreasing EHEC verotoxin production and host receptor expression, rather 
than interference with toxin binding to the receptor.  
6. Conclusion 
In summary, results of this study indicated that Se could potentially be used to attenuate 
EHEC infection by reducing verotoxin-mediated pathogenesis. The SIC of Se at which the down-
regulation of Gb3 expression observed in this study is approximately at the recommended upper 
tolerable level (400 µg), and half of the no-observed-adverse-effect level (NOAEL) of selenium 
(800 µg/day) [61, 62].  Therefore, the down-expression of Gb3 on host cells is not expected to 
occur at the much lower daily intake levels of Se. Further studies are needed to unveil the molecular 
mechanisms behind the anti-verotoxin effect of Se on EHEC and its down-regulation of Gb3 on 
host cells. Moreover, the effective blood concentration of Se required for the anti-verotoxin 
property and its pharmacokinetics in a living system needs to be determined.  Our follow up in 
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Figure 1: Effect of Se on extracellular verotoxin concentration. 
 
Three strains of EHEC (EDL 933, E163, and E137) were separately cultured with or without the 
SIC of Se (30 mM) at 37°C for 24  h, and extracellular verotoxin in cell-free culture supernatant 
was determined by ELISA. Bars with different letters (a and b) denote significant difference 









Figure 2: Effect of Se on intracellular verotoxin concentration. 
 
Three strains of EHEC (EDL 933, E163, and E137) were separately cultured with or without the 
SIC of Se (30 mM) at 37°C for 24  h, and intracellular verotoxin concentration in cell lysate was 
determined by ELISA. Bars with different letters (a, and b) denote significant difference between 










Figure 3. Effect of Se on verotoxin gene expression. 
 
RNA extracted from EHEC grown with and without SIC of Se was converted to cDNA, and 
subjected to RT-qPCR using published primers specific for stx1 and stx2. The relative gene 
expression was calculated using the 2−ΔΔCt method. Bars with different letters (a, b) denote 









Figure 4.  Effect of Se on Gb3 receptor expression on Ramos cells. 
 
 
The cells were treated with the SIC of sodium selenite for 1 h, sedimented by centrifugation at 300 
x g for 10 min, and washed with fluorescence activated cell sorting (FACS) buffer (PBS containing 
0.1% fetal bovine serum and 0.01% sodium azide). The cells were subsequently labeled with FITC 
mouse anti-human CD77/Gb3 antibody and incubated for 30 min on ice. Appropriate unlabeled, 
labeled and isotype controls were included. Histograms showing Gb3 receptor fluorescence 
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intensity of gated Ramos cells. FACS sorted Ramos cells after treating with selenium compared to 
unlabeled, labeled Ramos cells and isotype control. 
Figure 5. Effect of Se on Gb3 gene expression in Ramos cells. 
 
RNA extracted from Ramos cells grown with and without SIC of Se was converted to cDNA, and 
subjected to RT-qPCR using published primers specific for genes involved in the synthesis of Gb3. 
The relative gene expression was calculated using the 2−ΔΔCt method. Bars with different letters 








Figure 6A. Globotriaosylceramide (Gb3) content in Vero cells. 
 
Each experimental lane represents different concentrations (µg/ml) of Gb3 standard and the 
extracted sample.  
Figure 6B: Gb3 binding. 
 
Gb3 was extracted from the Vero cells using thin layer chromatography and coated on to 
microdilution plates. Elisa was performed to detect the percentage availability of Gb3 receptor for 
binding with the antibody after incubating with the verotoxin in presence or absence of Se. Even 
though, there was decreased binding of receptor with the toxin in the presence of Se, the percentage 
availability of Gb3 receptor was not significantly different between toxin treatment and toxin plus 
Se treatment (P=0.11).                                        
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Table 1:  List of primers used in the study 


































































































Enterohemorrhagic Escherichia coli (EHEC) is a pathogen causing severe bloody diarrhea, 
hemorrhagic colitis, and a potentially fatal renal disease. Due to bacterial lysis and release of 
bacterial cytotoxins called verotoxins (VT) in patients, the use of antibiotics for treating EHEC 
infection is contraindicated. Thus, there is a need for alternate strategies for controlling EHEC 
infection in humans. This study investigated the efficacy of rutin (RT), a GRAS-status (Generally 
recognized as safe) antimicrobial flavonoid, in attenuating EHEC virulence in vitro. The effect of 
sub-inhibitory concentration (SIC, highest concentration neither bacteriostatic nor bactericidal) of 
RT on EHEC motility, attachment to intestinal epithelium (Caco2 cells,) VT production, VT-
induced cytotoxicity, and VT binding to cell surface receptor, Gb3, was studied. Moreover, the 
anti-verotoxin effect of RT was investigated by determining the binding ability of RT to VT by 
molecular docking and protein-ligand interactions.  
Rutin decreased EHEC motility and attachment to Caco2 cells (P<0.05). Rutin inhibited 
both extracellular and intracellular VT production by ~ 40 to 60% in EHEC, compared to untreated 
controls (P < 0.05).  RT-qPCR results revealed that RT down-regulated the transcription of genes 
mediating EHEC attachment (eae) and VT synthesis (stx1 and stx2) (P < 0.05). Verotoxin binding 
to Gb3 receptor was decreased in the presence of RT (P < 0.05). Further experiments revealed that 
RT can competitively bind VT at the receptor binding sites, thereby possibly inhibiting toxin-
induced pathology.  Results justify follow-up animal studies for validating the anti-verotoxin effect 






Enterohemorrhagic Escherichia coli O157: H7 (EHEC) is a subset of Shiga toxin 
producing E. coli, which causes hemorrhagic colitis and hemolytic uremic syndrome (HUS) in 
humans.  EHEC poses a significant public health concern owing to its ability to produce fatal food-
borne infections with a low infectious dose (2–2,000 cells) (Buchanan, 1997; Strachan et al., 2005). 
EHEC is responsible for causing over 63,000 estimated cases of foodborne illnesses annually in 
the United States, costing the U.S. economy an estimated $1 billion per year (Schraff, 2012). Cattle 
serve as the principal reservoir of EHEC (Laegreid et al 1999, Shere et al., 1998), with fecal 
contamination of food products as an important source of human infections. A wide range of foods 
have been implicated as vehicles of EHEC infection, with a majority of outbreaks linked to the 
ingestion of undercooked ground beef products (Croxen et al., 2013; Shere et al., 1998; Naylor et 
al., 2003). 
EHEC colonization of the human gut mucosa is mediated by bacterial motility, which 
enables the pathogen to traverse through the intestine to reach a favorable niche (Tobe et al., 2011). 
In addition, several adherence factors, including intimin, fimbriae and pili contribute to EHEC 
adherence and colonization of host mucosal surface (Nataro and Kaper, 1995; Wang et al., 2006; 
Serna and Boedeker, 2008). After attaching to intestinal epithelial cells, EHEC elaborates 
verotoxins (VT), the key virulence factor that brings about EHEC pathogenesis and causes HUS 
in humans (Sakagami et al., 2001). Verotoxins are of two types, verotoxin 1 and verotoxin 2, and 
they can be extracellular and intracellular. The extracellular VT is secreted to the growth 
environment, whereas the intracellular portion gets accumulated in bacterial cells and is released 
when cells are lysed (Yuk and Marshall, 2003, 2004, 2006).  
Verotoxins belong to the AB5 toxin family with A and B subunits. The pentameric B 
subunit of VT binds to the target host cell glycolipid receptor, globotriaosylceramide (Gb3), and 
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gets internalized by receptor-mediated endocytosis. After internalization, the subunit A of VT 
interacts with 60S ribosomal subunit and inhibits protein synthesis, thereby leading to cell death 
or apoptosis (Weeratna and Doyle, 1991; Tam and Lingwood, 2007).  Thus, an adequate 
expression of Gb3 receptor and effective VT binding are pre-requisites for toxin-mediated 
pathogenesis.  
Verotoxins are encoded by stx1 and stx2 genes, which are located within Stx-encoding 
phages present in the bacterial chromosome (Shaikh and Tarr, 2003; Mauro and Koudelka, 2011). 
Antibiotics can induce phage lytic cycle through SOS response (global response to DNA damage 
in which the cell cycle is arrested), thereby augmenting the expression of stx genes encoded within 
the prophage.  Since this results in increased VT production (Su and Brandt, 1995; Neely and 
Friedman, 1998; Suwalak and Voravuthikunchai, 2009), the use of antibiotics for treating EHEC 
infections is contraindicated (Croxen et al., 2013). Antibiotic usage in patients has been linked to 
enhanced risk of systemic complications such as acute renal failure (Zhang et al., 2000) and 
elevated mortality in patients (Matsushiro et al., 1999). Moreover, antibiotics can negatively affect 
the normal gut flora, which in turn can lead to EHEC overgrowth (Su and Brandt, 1995). Thus the 
current treatment options against EHEC infections are mainly supportive (Ho et al., 2013), 
underscoring the critical need for alternate approaches for controlling EHEC in humans. 
Prospective strategies for treating EHEC infections target VT, its toxin receptor and their 
interaction, with the aim of decreasing cellular uptake of toxin and downstream pathology 
(Goldwater and Bettelheim, 2012; Pacheco and Sperandio, 2012). 
In light of microbial antibiotic resistance, an emerging strategy progressively explored for 
controlling infectious diseases is called antivirulence therapy,  which primarily targets microbial 
virulence rather than growth, where bacterial factors critical for causing infection or disease in 
143 
 
hosts are attenuated (Defoirdt, 2016; Rasko and Sperandio, 2010; Khodaverdian et al., 2013; 
Clatworthy et al., 2007; Escaich, 2008). Antivirulence agents being neither bacteriostatic nor 
bactericidal, potentially lead to a reduced selection pressure for resistance development (Rasko 
and Sperandio, 2010; Hung et al., 2005; Cegelski et al., 2008; Mellbye and Schuster, 2011) 
compared to conventional antimicrobials, and are minimally deleterious on the host gut microflora.  
Phytochemicals constitute an important ingredient of traditional and herbal medicine. 
Several studies have documented a wide range of beneficial properties with phytochemicals, 
ranging from antiseptic, anti-inflammatory, antioxidant and antimicrobial effects (Deans and 
Ritchie; 1987; Baratta et al., 1998a, b; Alma et al., 2003). Rutin (RT, quercetin-3-rhamnosyl 
glucoside) is a natural flavone derivative that was first extracted from buckwheat. Other sources 
of RT include asparagus, rhubarb, and berries (Kreft et al., 2006). Various pharmacological effects 
of RT, including anti-allergic, anti-inflammatory, antitumor, antibacterial, antiviral and 
antiprotozoal properties have been reported (Yang et al., 2008). Based on the hypothesis that RT 
attenuates EHEC virulence, disengages VT with its biochemical interactions, and impedes toxin-
mediated pathogenesis, this study investigated the potential of RT as a next generation drug 
candidate to treat EHEC infections effectively. 
Materials and Methods 
Bacterial strains and culture conditions 
Three strains of EHEC (EDL 933, E163, and E137) were used in this study. Each strain of EHEC 
was cultured separately in 10 ml of sterile tryptic soy broth (TSB, Sigma-Aldrich, St. Louis, MO) 
with incubation at 37°C for 18 h. Following incubation, bacterial cultures were pelleted by 
centrifugation (3600 ×g for 15 min), washed twice and suspended in 10 ml of sterile phosphate 
buffered saline (PBS, pH 7.0). The bacterial count in each of these cultures was determined by 
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plating 100 µl of ten-fold serial dilutions on duplicate tryptic soy agar (TSA, Sigma-Aldrich), 
Sorbitol MacConkey agar (SMA, Sigma-Aldrich), followed by incubation at 37°C for 24 h.  
Sub-inhibitory concentration (SIC) of RT 
 
The SIC of RT (Sigma-Aldrich, MW: 610.52) was determined, as previously described (Surendran 
Nair et al., 2016). Tryptic soy broth containing RT ranging from 0 to 0.5% (v/v) in increments of 
0.01% was inoculated with each strain of EHEC (5.0 log CFU/ml) and incubated at 37°C for 24 h. 
Control samples containing TSB without RT were also included. After 24 h of incubation, samples 
were serially diluted (1:10) in PBS and appropriate dilutions were surface-plated on TSA. The 
plates were incubated at 37°C for 24 h. The highest concentration of RT that permitted bacterial 
growth similar to the control after incubation at 37°C for 24 h was taken as the SIC for the study. 
Bacterial motility assay 
The effect of RT on EHEC motility was determined according to a previously published method 
(Wang et al., 2006). RT at its SIC was added to petriplates containing 20 ml of LB broth containing 
0.3% agar. The plates were mixed by swirling for 15-20 sec. A volume of 10 µl of EHEC culture 
containing ~ 6.0 log CFU was inoculated at the center, and the plates were kept still for 1 h at 
25°C, followed by incubation at 37°C for 12 h. After incubation, the zone of motility was 
measured.  
Bacterial adherence assay 
The effect of RT on EHEC adherence to human colonic epithelial cells (Caco-2) was investigated 
as described (Xicohtencatl-Cortes et al., 2007).  Caco-2 cells were maintained in Dulbecco's high 
glucose Modified Eagle Medium (DMEM, Gibco, Invitrogen) containing 10% FBS at 37°C under 
5% CO2.  Polystyrene 24-well plates were seeded with Caco-2 cells at a density of 1 × 10
5 cells 
per well, and allowed to form a monolayer in high glucose DMEM containing 10% FBS. The 
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monolayer was washed three times with PBS and inoculated separately with each EHEC strain at 
6 log CFU/well (MOI 1:10), followed by treatment with RT. The cells were incubated for 2 h and 
washed three times with PBS to remove unattached bacteria. Subsequently, the cells were 
permeabilized with 0.1% triton X-100 for 15 min to enable the quantification of the bacterial 
population adhered to cells by serial dilution and plating on TSA and SMA.  
Effect of RT on verotoxin production 
Verotoxin produced by each EHEC strain was quantified by enzyme-linked immunosorbent assay 
(ELISA) using the Premier EHEC test (Meridian Bioscience, Cincinnati, OH), as described 
previously (Yuk and Marshall, 2003; Staples et al., 2012). Briefly, TSB containing the SIC of RT 
was separately inoculated with each EHEC strain (~ 6.0 log CFU/ml) and incubated at 37°C for 
24 h. EHEC cultured in the absence of RT was included as control. After incubation, the bacterial 
cells were pelleted by centrifugation at 3,800× g for 15 min, and culture supernatant and cell pellets 
were separated. The final washed cell pellet was resuspended in Tris-EDTA lysis buffer, and 
bacterial cell membrane was disrupted using an ultrasonicator (Branson Digital Sonifier, Danbury, 
CT) at 50 W for 1 min. The extracellular and intracellular VT concentrations were be estimated in 
cell-free culture supernatant and cell lysate at both 0 and 24 h of incubation using the 
aforementioned ELISA kit. A standard curve of optical density at 450 nm versus known standard 
VT (BEI resources, Manassas, VA) concentration was created to determine the unknown VT 
concentration in control and RT-treated samples (Yuk and Marshall, 2003).  
Virulence gene expression using real-time quantitative PCR (RT-qPCR) 
The effect of RT on the transcription of genes encoding VT (stx1 and stx2), motility (motB) and 
adherence (eae) was investigated using RT-qPCR (Pollard et al., 1990) using the primers listed in 
Table 2. Each EHEC strain was grown overnight in TSB at 37°C with or without the SIC of RT, 
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and total RNA extracted using an RNeasy RNA isolation kit (Qiagen, Germantown, MD). The 
cDNA was synthesized using the I script cDNA synthesis kit (Biorad, Hercules, CA) and used as 
the template. RT-qPCR analysis of the verotoxin genes was performed using published primers 
(Pollard et al., 1990) and normalized against 16S rRNA gene expression. Twenty-five microliter 
reactions were performed in duplicate using iTaq SYBR RT-PCR (Bio-Rad) and repeated three 
times. The relative fold change in gene expression was calculated using the 2−ΔΔCt method (Livak 
et al., 2001). 
Neutral red cytotoxicity assay 
The effect of RT on the cytotoxicity of EHEC culture supernatant and its efficacy in protecting 
host cells from VT was determined using neutral red cytotoxicity assay (Bouzari et al., 2009). 
Vero cells (CCL-81, ATCC, Manassas, VA) were plated in 96-well plates and grown to sub-
confluence in Eagle’s minimal essential medium (MEM, Gibco, Invitrogen) containing 10% fetal 
bovine serum. Cells were then washed and treated with the culture supernatant of EHEC grown 
with RT overnight. In addition, Vero cells were also treated with SIC of RT and VT extracted from 
an overnight culture of EHEC. Appropriate cell and solvent controls were included. Two hundred 
microliters of freshly diluted neutral red in MEM medium were then added to a final concentration 
of 50 ng/ml and cells were incubated for an additional 3 h at 37°C in 5% CO2. Cells were washed 
with 1% CaCl2 and 4% formaldehyde, and solubilized in 1% acetic acid and 50% ethanol. 
Absorption in each well was read in a plate spectrophotometer at 546 nm. Results were expressed 
as neutral red uptake percent, with 100% representing cells incubated under identical conditions 
but without toxin treatment. 
Effect of RT on VT binding to Gb3 receptor 




To detect levels of available Gb3 on Vero cells for VT binding in the presence of RT, 
immunofluorescent staining was done (Zumbrun et al., 2010). Briefly, Vero cells were grown in 
MEM, containing 10% FBS on Lab-Tech four-chamber no. 1 borosilicate glass coverslips (Lab-
tek, Nalge Nunc International, Rochester, NY). The cells were stimulated with the inflammatory 
factor, TNFἁ (100U/ml; Sigma Aldrich) 24 h prior to treatment. Binding of VT to cells was then 
be facilitated by incubating with Stx1 holotoxin (NR-857; BEI resources, Manassas, VA) (0.1 
ng/µl MEM) overnight at 37°C in the presence or absence of SIC of RT. The treated wells were 
then gently washed with PBS and blocked with PBS containing 3% bovine serum albumin (BSA) 
for 45 min. FITC-conjugated mouse anti-human CD77/Gb3 antibody (BD Bioscience, San Jose, 
CA) (diluted 1:50 in PBS), or PBS (negative control) was added to appropriate wells and incubated 
for 1 h on ice. Cells were again washed with PBS and counterstained with 0.01% Hoescht blue 
dye. The stained cells were assessed with a Zeiss Axiovert 200M fluorescent microscope 
Isolation and quantification of Gb3 
Gb3 receptor was isolated from Vero cells as described previously (Hughes et al., 2000; 
Surendran_Nair et al., 2016).   Vero cells (CCL-81, ATCC) were grown in Eagle’s minimal 
essential medium (MEM, Gibco, Invitrogen, city, State) containing 20% FBS in six-well 
polystyrene plates, and growth was arrested at confluence by transferring cells to serum deficit 
medium. The cells were stimulated with the inflammatory factor, TNFἁ (100U/ml; Sigma-Aldrich) 
for 24 h followed by the extraction of total cellular lipids.  The cells were washed with ice-cold 
PBS (pH 7), scraped off the plates and centrifuged at 500 x g for 10 min. The cell pellet was then 
lysed using an ultrasonicator at 50 W for 5 min. Subsequently, cells were extracted in 1ml of 
chloroform: methanol: water solvent (5:10:3) three times, and dried under nitrogen gas. The total 
dried lipid was suspended in 2:1 chloroform: methanol, and separated on silica gel thin layer 
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chromatography plates (10 x 20 cm, Sigma-Aldrich) by ascending chromatography in chloroform: 
methanol: water (65:35:8) solvent system. The lipid content on silica plates was then visualized 
with iodine vapor. The Gb3 standard (Ceramide Trihexosides Gb3, Matreya LLC, and PA) was 
run at different concentrations (10 to 40 µg) on TLC plates to identify the glycolipid of interest 
and determine the approximate amount of Gb3 extracted from the cells. Additionally, a standard 
curve of optical density at 490 nm versus Gb3 concentration (µg/ml) was used to determine the 
unknown concentration of Gb3 extracted from the cells.  
The effect of RT on VT binding to Gb3 receptor was determined according to a published 
protocol (Ashkenazi and Cleary, 1989).  The extracted Gb3 was retrieved from the TLC plate 
above and dissolved in 2:1 chloroform: methanol solvent. Polystyrene microdilution plates (Fisher 
Scientific, Pittsburg, PA) were inoculated with Gb3 (36 µg/ml), left uncovered for 4 h at 25oC for 
the evaporation of the diluent, and subsequently washed with Tween 20-PBS buffer. Verotoxin 
extracted from an overnight culture of EHEC was added to the plates (50 ng/well), and allowed to 
bind to the receptor with or without the SIC of RT at 37°C for 1 h.  Following this, mouse anti-
human CD77/Gb3 antibody (BD Bioscience, Billerica, MA) was added to the wells at 1:1000 
dilution, and allowed to bind to Gb3 for 1 h at 37°C. Subsequently, after washing with Tween-
PBS, peroxidase conjugated rabbit anti-mouse immunoglobulin G (Promega, Madison, WI) was 
added and incubated at 37°C for another hour. The substrate ortho phenyl diamine (0.4 mg/ml, 
Sigma-Aldrich)-0.1% H2O2 in citrate-phosphate buffer (25 mM citrate, 50 mM phosphate, pH 5) 
was allowed to react with the available enzyme peroxidase in the well for 15 min at room 
temperature following the washing step. The supernatants from the wells were transferred to new 
plates after incubation and the absorbance were measured at 490 nm. Wells with 0.1% BSA in 
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0.05% Tween 20-PBS (diluent in which samples were diluted) instead of the sample served as 
negative controls.  
Flow cytometry 
The effect of  RT on surface expression of the Gb3 receptor protein in Ramos cell line (human 
Burkitt’s lymphoma; ATCC CRL-1596) was studied using flow cytometry (Tetaud et al., 2003; 
Desselle et al., 2012). Ramos cells were maintained in Roswell Park Memorial Institute medium 
(RPMI, Gibco, Invitrogen) containing 20% FBS at 37°C under 5% CO2.  The cells (~1 x 10
4 per 
well) were seeded onto a 6-well plate and will be allowed to grow overnight at 37°C in the presence 
of 5% CO2. The cells were then treated with the SIC of RT for 1 h, sedimented by centrifugation 
at 300 x g for 10 min and washed with fluorescence-activated cell sorting (FACS) buffer (PBS 
containing 0.1% fetal bovine serum and 0.01% sodium azide). The cells were subsequently 
resuspended in FACS buffer and labeled with FITC-conjugated mouse anti-human CD77/Gb3 
antibody (BD Bioscience) for 30 min on ice. Unlabeled control wells (cells neither treated with 
RT nor incubated with antibody), labeled control wells (cells not treated with RT, but labeled with 
antibody) and isotype control wells (cells not treated with SIC of RT, but labeled with FITC mouse 
IgM ĸ (BD Bioscience) were included. Isotype controls were used to confirm the primary antibody 
specificity and determine any non-specific reactivity of antibody with the cells (Keeney et al., 
1998). After labeling, cells were washed twice with FACS buffer and analyzed by flow cytometry 
using a BD FACS-Calibur flow cytometer. The mean fluorescence intensity was calculated for all 
the samples (Keeney et al., 1998; Herzenberg et al., 2006). 
Molecular modeling and docking 
 
In order to test the hypothesis that RT interacts with the toxin, inducing a protein modification, 
molecular modeling and docking were done using the Schrödinger small-molecule drug discovery 
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suite (version: 2017 – 2) as described by Benedik et al (2014) and. Friesner et al (2004). The details 
on the binding sites of VT we discussed in this study were extracted from the crystal structures 
PDB 4M1U and 1BOS. Owing to the better resolution for testing the plausible binding affinity of 
RT to toxin, docking experiments were done using the 1.53 Å resolution crystal structure of Stx2 
(PDB ID 4M1U). Prior to the docking experiments the crystal structure was prepared (e.g. H atoms 
added, protonation and tautomeric states assigned, and H-bond donor/acceptor groups reoriented) 
with the Protein Preparation module in Maestro version 10.6.014 (Sastry et al., 2013). 
The grid-based ligand docking with energetics (Glide) methodology in standard precision mode 
was used to dock rutin into the five Site 1 and five Site 2 carbohydrate-binding pockets identified 
on the B5 subunit of Stx (Halgren et al., 2004; Friesner et al., 2004). For binding pockets shown 
to be occupied by a co-crystallized disaccharide analogue of Gb3, or methyl α-D-GalNAcp-
(1→4)-β-D-Galp-(1-O), the receptor grid was centered at the location of the bound molecule. For 
unoccupied sites in the crystal structure, the centroid of the residues defining the pocket was used 
to position the docking grid. The top ten poses from each of the 10 Site 1 and Site 2 binding sites 
were analyzed, and the best-ranked poses for Site 1 and Site 2 pockets were retained. 
Statistical analysis 
All experiments included duplicate samples for each treatment and control, and were replicated 
three times. The data were analyzed using a generalized linear model of PROC GENMODE 
procedure of SAS 9.3 version (SAS institute, Cary, NC).  The differences between the means were 
compared using least significant difference (LSD) test and the significance was tested at   P<0.05. 
Results 
The highest concentration of RT which was neither bacteriostatic nor bactericidal was first 
determined. RT was dissolved in dimethyl sulfoxide (DMSO) and the final concentration of 
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DMSO used in the treatment solution was 1%, which did not affect EHEC viability, as previously 
reported by Markarian et al (2002). The average initial EHEC count in RT-treated and control 
samples was ~ 5.0 log CFU/ml. After 24 h of incubation at 37°C, ~ 8.5 log CFU/ml of EHEC was 
recovered from control and 1.7 mM RT-treated samples, thereby confirming that the 
aforementioned RT concentration was the SIC. Further studies were conducted using this 
concentration unlessnoted otherwise. 
EHEC motility was affected in the presence of RT in vitro 
Bacterial motility is essential for host-microbial interactions, colonization, and virulence in the 
host (Josehans and Suerbaum, 2002). Therefore, the effect of RT on the motility of EHEC was 
determined. The extent of bacterial spread over a constant period of time on semi-solid LB agar 
plates was estimated by measuring the zone of motility, as shown in Figure 1. In the presence of 
RT, the zone of motility was significantly reduced in all three strains of EHEC (EDL 933, E163 
and E137), indicating an anti-motility effect of the treatment (P<0.05). The downstream protein 
involved in the chemotaxis of EHEC, the motB mRNA expression, was also downregulated in the 
presence of RT (Figure 2).  
Decreased EHEC attachment to human intestinal cells in the presence of RT 
Being an extracellular pathogen, EHEC requires firm adhesion to host intestinal epithelial cells in 
order to colonize, persist and establish disease in the host. It also contributes to tissue tropism 
during the process of infection (McWilliams and Torres, 2014; Shoaf‐Sweeney and Hutkins, 
2008). Cell culture studies revealed that RT decreased EHEC adhesion to human colon epithelial 
carcinoma cells (P<0.05) (Figure 3). When co-incubated with RT, the number of EHEC adhered 
to the intestinal cells were lesser than those infected with EHEC alone (P<0.05). Since eae gene 
and its protein product intimin play a significant role in the initial EHEC attachment and 
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colonization of the intestine, RT-qPCR studies revealed that RT down-expressed the respective 
genes which contributed to the phenotype observed (Figure 4). 
Rutin reduced extracellular and intracellular verotoxin production 
Verotoxins are the major virulence factors elaborated by EHEC. They are pentameric cytotoxins 
causing apoptosis following entry into the host cells. Since antibiotics can cause bacterial lysis and 
can release increased amount of toxins to host cells, they are not commonly used for treating EHEC 
infections in humans. Therefore, EHEC cultures (EDL 933, E163 and E137) were treated with the 
SIC of RT, which is neither bacteriostatic nor bactericidal. The basal level of extracellular VT 
concentration in RT treatment and control at 0 h was ~ 5 + 1 ng/ml, irrespective of the strains, 
whereas the intracellular VT concentration was under the detection limit (<1 ng/ml). After 24 h of 
incubation, the extracellular VT concentration in the presence of RT was decreased to < 100 ng/ml 
compared to control (350-400 ng/ml) (P < 0.05) (Figure 5). Similarly, the intracellular VT level in 
RT-treated EHEC was reduced by 80–90% after 24 h of incubation (P < 0.05) (Figure 6). However, 
the magnitude of extracellular and intracellular VT production was found to be strain specific. 
Among the three different strains, EDL 933 produced the highest amount of extracellular and 
intracellular toxins. Additionally, in accord with the ELISA results, RT-qPCR data revealed that 
RT downregulated both stx1 and/or stx2 expression in all the three strains of EHEC (P < 0.05) 
(Figure 7). 
Rutin protected Vero cells from the cytotoxic effects of verotoxin 
Cytotoxicity of the Vero cells (African green monkey kidney cells) has been identified as the gold 
standard assay for determining the presence of VT and its cytotoxicity. Therefore, in this study, 
we determined the cytotoxic activity of VT on Vero cells in the presence of RT by measuring cell 
viability using the neutral red (NR) uptake assay (Ma´rquez et al., 2014). Neutral Red assay is 
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based on the ability of viable cells to incorporate and bind the vital dye called neutral red in 
lysosomes. Consequently, when the cell dies, the dye cannot be retained in the cells, and thus the 
amount of retained dye is proportional to the number of viable cells. The linear relationship 
between the number of live cells and absorbance at 540 nm after NR test subsequently identifies 
the cell viability and/or cytotoxicity levels.  
For this purpose, confluent Vero cells were incubated with SIC of RT and VT extracted 
from the overnight culture of type strain EDL 933 (Kavaliauskiene et al., 2016). Incubation with 
VT produced a significant reduction in the cell viability, whereas a diminished cytotoxic effect 
was observed when cells were co-incubated with RT and VT (Figure 8). In addition, as expected, 
the supernatant (containing VT) retrieved from EHEC culture grown in the presence of RT did not 
produce any cytotoxicity on Vero cells, confirming the decreased production by EHEC. However, 
the supernatant from cultures grown without RT caused a complete rounding of Vero cells (data 
not shown). 
Verotoxin binding to Gb3 receptor decreased in the presence of RT 
As mentioned before, the efficient binding of VT to Gb3 is a prerequisite for toxin induced 
cytotoxicity and further downstream pathology. Subsequent to decreased cytotoxicity observed in 
the presence of RT, we tested the hypothesis that RT interfered with the effective binding of toxin 
to the receptor, using immunofluorescent staining of Vero cells (Zumbrun et al., 2010). As seen in 
Figure 9, in Vero cells not exposed to VT, a high green fluorescence intensity was observed 
indicating the maximum availability of Gb3. However, the cells treated with VT alone showed 
significantly less green fluorescence indicating the increased binding of the receptor with toxin 
leaving less free receptors behind. Furthermore, in Vero cells treated with VT in the presence of 
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RT, there was significantly greater green fluorescence indicating more available Gb3 and less 
efficient binding to the toxin.  
As a follow up for the quantitative estimation, the glycolipid receptor protein, Gb3, was 
isolated from Vero cells and the concentration was estimated from a standard curve generated 
using different concentrations of Gb3 standard. The average yield of Gb3 was found to be ~ 36 
μg/ml (Figure 10A). The extracted Gb3 was then used to determine the effect of RT on toxin 
binding to the receptor using ELISA. As shown in Figure 10B, when VT alone was added to wells 
coated with Gb3, the absorbance decreased to 49% compared to control, indicating a decreased 
Gb3 availability due to active binding of toxin to receptor. However, the toxin binding to the 
receptor was found to be impeded in the presence of RT leaving more Gb3 available for the 
antibody to bind when VT was added with RT. Thus, RT alone affected VT binding to the receptor 
compared with control samples (P < 0.05). 
Effect of RT on Gb3 receptor expression 
To determine if RT exerts any inhibitory effect on Gb3 expression, we used Ramos cells, since 
these are known to overexpress Gb3 receptor, and have been extensively used for studying 
physicochemical characteristics of Gb3 receptor and its expression (Furukawa et al., 2002; 
Engedal et al., 2011). In order to assess the cell surface expression of Gb3 in Ramos cells (human 
Burkitt’s lymphoma; ATCC CRL-1596), the mean fluorescence intensity of gated population of 
live cells was measured using flow cytometry. Live cell population as determined by side scatter-
forward scatter gate (confirmed with propidium iodide staining) were analyzed. However, the 
mean fluorescence of cells treated with RT was not different compared to control cells (P>0.05), 
thereby suggesting that Gb3 expression in host cells was not modulated in the presence of RT 
(Figure 11).  
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On other hand, this finding along with the decreased binding of VT to the Gb3 led us to 
hypothesize potential structural interactions of RT with the binding sites of the VT. To test this, 
we investigated the binding interactions experimentally using molecular docking and protein-
ligand interactions.   
Molecular modeling and docking 
To understand the molecular basis of RT-induced VT inhibition, we performed simulations via the 
grid-based ligand docking with energetics (Glide) method using the Schrödinger small-molecule 
drug discovery suite (Version: 2017 – 2). Since we had no information where the RT binding sites 
might be, we had to determine the potential binding site locations for our ligand using blind 
docking. Subsequently, RT was found docked into the pentameric array of receptor binding sites 
1 and 2 identified in the Stx crystal structures (PDB 4M1U and 1BOS) (Figure 12A). Furthermore, 
to predict the plausibility of competitive binding hypotheses, the binding scores were determined 
in comparison to the disaccharide receptor analog (Methyl α-D-GalNAcp-(1→4)-β-D-Galp-(1-O)) 
identified by Jacobson et al. (2014).  
Figure 12B shows the molecular surfaces for Site 1 (blue) and Site 2 locations (red), the co-
crystalized disaccharide (green), and the best ranked docking poses for RT (yellow) in all Site 1 
and Site 2 grooves. As mentioned, the docking scores (Table 1) and docking poses (Figure 13) 
were then compared to the co-crystalized disaccharide, methyl α-D-GalNAcp-(1→4)-β-D-Galp-
(1-O), the analogue of Gb3. 
As observed in Table 1, RT is predicted to bind with comparable or slightly better affinity 
to the receptor binding sites of StxB compared to the co-crystalized disaccharide ligand. Figure 
12C demonstrates that these relatively favorable binding scores are attributable to the 
complementarity of RT structure for the topology of both Site 1 and Site 2 binding grooves on the 
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B subunit. Rutin better utilizes an array of H-bonding and - stacking interactions, which are not 
accessible to the disaccharide Gb3 analogue. Interestingly, the best docking pose for RT in Site 1 
binding grooves coincided with the disaccharide ligand, whereas different Site 2 binding pockets 
were preferred by the disaccharide and RT. This may reflect different binding site conformations 
in the crystal structure of the protein. Collectively, these docking results suggest that RT is a 
promising lead for structure-activity investigations on the anti-verotoxin effect of phytochemicals. 
Although the docking results suggest the plausibility of competitive binding hypothesis, these 
calculations do not predict which of the possible inhibitory mechanisms is operative or more 
relevant.  
Discussion 
In this study, we investigated the phytochemical, RT, as a potential antivirulence agent to 
attenuate EHEC’s determinants contributing to pathogenesis in humans. To this end, we 
demonstrated that RT at its highest SIC level did not disrupt bacterial growth or viability, but rather 
disarmed the pathogen using multiple mechanisms.  
Motility and host tissue attachment are critical processes required for EHEC intestinal 
colonization and pathogenesis. Rutin was effective in reducing both these virulence factors in all 
three EHEC strains. Intimin is an adhesin in EHEC critical for intimate attachment of the pathogen 
to host tissue (Frankel et al., 1998; Hicks et al., 1998). It is documented that EHEC mutants lacking 
intimin displayed diminished intestinal colonization and virulence in calves and gnotobiotic piglets 
(Dean-Nystrom et al., 1998; Tzipori et al., 1995). RT-qPCR data revealed that RT significantly 
decreased the transcription of intimin-encoding gene, eae in EHEC. 
As discussed before, verotoxins are the most significant virulence factors in EHEC. 
Therefore interventions inhibiting VT synthesis, toxin binding, uptake, or function represent a 
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promising avenue for the development of antivirulence therapy against the pathogen. In this study, 
we identified the efficacy of RT to impede both extracellular and intracellular VT production in 
all three EHEC isolates, which concurred with RT-qPCR data revealing RT-mediated 
downregulation in the expression of stx1 and stx2 genes. Previously, green tea catechins, 
epigallocatechin gallate and gallocatechin gallate were documented to exert an inhibitory effect on 
extracellular VT secretion in EHEC (Sugita-Konishi et al., 1999). Similarly, Takemasa et al. (34) 
reported a concentration-dependent reduction in EHEC extracellular and intracellular VT 
expression by the essential oil, eugenol. Likewise, Baskaran et al. (2016) observed an inhibitory 
effect of several essential oils, including trans-cinnamaldehyde, carvacrol, and thymol on EHEC 
motility, adhesion to human intestinal cells and VT synthesis. 
Gb3 is the only functional receptor for VT in mammals and cell surface expression of this 
receptor and effective VT binding to the receptor are prerequisites for toxin sensitivity and toxin-
induced pathology in the host (Okuda et al., 2006; Sandvig et al., 1992, 1994; 2001; Jacewiz et al., 
1994; Lingwood 1994). Consequently, we investigated the effect of RT on reducing VT binding 
to Gb3 receptor using an in vitro Gb3 binding assay. The results showed a significant decrease in 
toxin binding to Gb3 in the presence of RT (P< 0.05). These results were confirmed by 
immunofluorescence staining of Vero cells, where a greater proportion of available Gb3 and 
decreased binding to the toxin were observed in the presence of RT compared to control. However, 
the flow cytometry data revealed no effect of RT on Gb3 expression. These results indicate that 
the potential therapeutic effect of RT is mainly mediated by decreasing VT production and toxin-
receptor interaction rather any direct effect on Gb3 receptor expression. Consequently, we 
investigated the probability of structural interactions of RT with VT. Several flavonoids have been 
identified to possess potential binding sites on enterotoxins, including the staphylococcal 
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enterotoxins (Benedik et al., 2014). Our molecular docking results suggested that RT can bind to 
two of the three receptor binding sites on each monomer subunit, which is likely to influence 
receptor binding affinity of the toxin. The crystal structure of radially symmetric pentameric B 
subunit (B5) possess three binding sites for Gb3, numbered 1–3, for a total of 15 binding sites per 
pentamer (Figure 12A).  The results thus imply that RT could inhibit VT toxicity by effectively 
competing with the natural cell-surface Gb3 receptor for the carbohydrate binding sites of the 
holotoxin. In a study conducted by Dong et al., (2015), a structurally related phytochemical, 
baicalin inhibited Stx2 activity by directly interacting with toxin inducing protein oligomerization. 
Given the fact that the activities of RT and baicalin are similar and they share a high-level 
resemblance in their structures (Figure 13), we attempted to identify residues on Stx potentially 
involved in binding baicalin and RT. Although weak associations were identified in similar sites 
identified with baicalin, the hypothesis of protein oligomerization has to be further elucidated 
using techniques such as analytical centrifugation or crystallization of Stx with RT. Therefore 
further biochemical studies are warranted in this direction to the fully understand the anti-VT effect 
of RT.  
In conclusion, the potential efficacy of RT as an antivirulence agent to control EHEC 
pathogenesis has been identified and discussed in this manuscript. However, follow up in vivo 
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Figure 1 (Left panel). Effect of rutin on EHEC motility. In the presence of RT, the zone of motility 
was significantly reduced in all three strains of EHEC (EDL 933, E163 and E137), indicating an 
anti-motility effect of the treatment (P<0.05). Figure 2 (Right panel). Effect of rutin on EHEC 
motB mRNA expression. The protein involved in the chemotaxis of EHEC, the motB mRNA 


















Figure 3 (Left panel). Effect of rutin on EHEC adhesion to human intestinal cells. RT decreased 
all three strains of EHEC (EDL 933, E163 and E137) adhesion to human colon epithelial 
carcinoma cells (P<0.05). When co-incubated with RT, the number of EHEC adhered to the 
intestinal cells were lesser than those infected with EHEC alone (P<0.05).  
Figure 4 (Right panel). Effect of rutin on EHEC eae mRNA expression. Since eae gene and its 
protein product intimin play a significant role in the initial EHEC attachment and colonization of 
the intestine, RT-qPCR studies revealed that RT down-expressed the respective genes which 















Figure 5. Effect of rutin on extracellular verotoxin production (P<0.05). Figure 6. Effect of rutin 
on intracellular verotoxin production (P<0.05). After 24 h of incubation, the extracellular VT 
concentration in the presence of RT was decreased to < 100 ng/ml compared to control (350-400 
ng/ml) (P < 0.05). Similarly, the intracellular VT level in RT-treated EHEC was reduced by 80–
90% after 24 h of incubation (P < 0.05). 
 
 
Figure 7. Effect of rutin on verotoxin gene transcription. RT-qPCR data revealed that RT 







Figure 8. Effect of rutin on Vero cell cytotoxicity using neutral red uptake assay (P<0.05). 
Confluent Vero cells were incubated with SIC of RT and VT extracted from the overnight culture 
of type strain EDL 933. Incubation with VT produced a significant reduction in the cell viability, 
whereas a diminished cytotoxic effect was observed when cells were co-incubated with RT and 
VT. Clear rounding was observed in cells incubated with verotoxin as observed in the light 


















Light microscopy images of Vero cells before neutral red assay 
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Figure 9: Effect of rutin on verotoxin binding to Gb3. Immunofluorescence staining using FITC 
labelled anti-Gb3 antibody (green) and the Hoechst staining for the nucleus (blue).  In Vero cells 
not exposed to VT, a high green fluorescence intensity was observed indicating the maximum 
availability of Gb3 whereas the cells treated with VT alone showed significantly less green 
fluorescence indicating the increased binding of the receptor with toxin leaving less free receptors 
behind. Furthermore, in Vero cells treated with VT in the presence of RT, there was significantly 
















Figure 10A. Globotriaosylceramide (Gb3) content in Vero cells 
 
Each experimental lane represents different concentrations (µg/ml) of Gb3 standard and the 
extracted sample.  
 
Figure 10B. Gb3 binding. Gb3 was extracted from the Vero cells using thin layer chromatography 
and coated on to microdilution plates. ELISA was performed to detect the percentage availability 
of Gb3 receptor for binding with the antibody after incubating with the verotoxin in presence or 
absence of RT. Results indicate, there was decreased binding of receptor with the toxin in the 
presence of RT, the percentage availability of Gb3 receptor was significantly different between 





Figure 11.  Effect of RT on Gb3 receptor expression on Ramos cells. The cells were treated with 
the SIC of RT for 1 h, sedimented by centrifugation at 300 x g for 10 min, and washed with 
fluorescence activated cell sorting (FACS) buffer (PBS containing 0.1% fetal bovine serum and 
0.01% sodium azide). The cells were subsequently labeled with FITC mouse anti-human 
CD77/Gb3 antibody and incubated for 30 min on ice. Appropriate unlabeled, labeled and isotype 
controls were included. Histograms showing Gb3 receptor fluorescence intensity of gated Ramos 
cells. FACS sorted Ramos cells after treating with RT compared to unlabeled, labeled Ramos cells 











Figure 12A.  (Adapted from Jacobson et al. (2014)). The Stx-
Gb3 receptor analog complex. The five B subunits are 
named B1 through B5. The bound carbohydrates are shown 
as spheres with oxygen and nitrogen atoms colored red and 
blue, respectively; the carbon atoms of the carbohydrate 
ligands bound in sites 1, 2, and 3 are colored in gray, slate, 
and gold, respectively. 
 
 
Figure 12B. The pentameric arrangement of the Site 
1 (blue) and Site 2 (red) carbohydrate binding sites 
of Stx. Only the molecular surfaces for these 
binding sites are shown for the protein. The co-
crystalized disaccharide and the best ranked 
docking poses for rutin in the two different types of 












Figure 12C. Poses of the co-crystalized Gb3 disaccharide analogue (left), and the docked rutin 
(right) are shown for Site 1 (top panel) and Site 2 (bottom panel). H-bonding and -stacking 
interactions are indicated with yellow and green dashed lines, respectively. Residues participating 







Figure 13. Chemical structure of RT in the context of the previously identified Stx favonol inhibitor 
baicalin. The flavonol core of both structures is depicted in blue. The glucuronic acid specific to 
baicalin is shown in green. The aromatic diol and α-L-rhamnopyranosyl-(1→6)-β-D-
glucopyranose moieties in red are specific to rutin. The black bond signifies that this glycosylated 














Table 1. Glide scores (kcal/mol) for the co-crystalized disaccharide and rutin in the carbohydrate 
binding sites of STX2.  
 




Rutin -5.73 -6.92 
 
 
Table 2: List of primers used in this study. 
Gene Oligonucleotide sequences (5'-3') 
16S rRNA  Forward CATTGACGTTACCCGCAGAA 
Reverse CGCTTTACGCCCAGTAATTCC 
eaeA Forward TGGTGGCGAATACTGGCGAGA 
Reverse TGTATGACTCATGCCAGCCGC 
motB Forward CAGGGGGAAGTGAATAAGCA 
Reverse TTCTAAACATCGGGCGATTC 
stx1 Forward GTGGCATTAATACTGAATTGTCATCA 
Reverse GCGTAATCCCACGGACTCTTC 































Enterohemorrhagic Escherichia coli O157: H7 (EHEC) is an important foodborne 
pathogen causing severe symptoms and mortality in humans. Verotoxins (VT) produced by 
EHEC are the most critical virulence factor for causing hemorrhagic colitis, hemolytic uremic 
syndrome, and renal failure. Antibiotics are contraindicated in the treatment against EHEC due 
to enhanced chances of renal failure and mortality stemming from increased bacterial release of 
VT in the presence of antibiotics. Therefore, there is significant interest in identifying effective 
treatment strategies against EHEC, especially those targeting the VT. Our previous studies 
indicated that rutin (RT), a phytochemical, and selenium (Se), a naturally occurring essential 
trace mineral, significantly inhibited VT synthesis in EHEC.  
Caenorhabditis elegans is a nematode, increasingly used as an invertebrate model to study 
microbial pathogenesis and validate in-infective strategies against pathogens.  Therefore, in this 
study, we used C. elegans as an in vivo model for studying the anti-EHEC activity of RT and 
Se. Supplementation of RT significantly increased the survival of EHEC-infected C. elegans 
compared to control worms. The survivability was increased by ~ 65% in infected worms after 
treating with RT for a period of 7 days (P < 0.05). However, RT failed to protect C. elegans 
when the worms were intoxicated directly with VT.  On the other hand, since Se was found to 
be lethal to C. elegans, a significantly lower concentration than that used in vitro was 
supplemented to EHEC-infected worms. However, at the lower concentration used, Se lacked 
anti-EHEC activity and the percentage survival of Se-treated worms was not significantly 
different from the infected control group (P > 0.05). The aforementioned results justify further 





Diarrheal diseases are the second major threat for global mortality among children (Lanata et al., 
2013; Walker et al., 2013). Enterohemorrhagic E. coli (EHEC) is one of the diarrheagenic 
pathogens causing lethal complications such as hemolytic uremic syndrome (HUS) and renal 
failure worldwide (Ciccarelli et al., 2013). The global burden of EHEC comprises of 2,801,000 
acute illnesses, 3890 cases of HUS, 270 cases of permanent end-stage renal disease (ESRD), and 
230 deaths annually (Majowicz et al., 2014). Unfortunately, the only mainstream therapy for 
EHEC-HUS are supportive care measures such as fluid resuscitation and dialysis, since antibiotics 
are contraindicated. Several studies reported increased chance of developing renal failure in 
children on antibiotic therapy for HUS associated with EHEC infection (Wong et al., 2000; 
Zimmerhackl, 2000; Safdar et al., 2002; Tarr et al., 2005). This is because conventional antibiotics 
usage is reported to exacerbate verotoxin-mediated cytotoxicity. Verotoxins (VT) are the key 
virulence factors of EHEC responsible for causing HUS in humans (Sakagami et al., 2001). EHEC 
produces verotoxin 1 and/or verotoxin 2, which are encoded by stx1 and stx2, genes respectively. 
Antibiotics enhance the replication and expression of these stx genes encoded within a 
chromosomally integrated lambdoid prophage genome, resulting in increased VT production. 
Antibiotics also cause phage-mediated lysis of the EHEC cell membrane, allowing the release and 
dissemination of VT into the environment (Karch et al., 1999; Matsushiro et al., 1999; Wagner et 
al., 2002). Therefore, there is immense interest among clinicians and scientists to explore alternate 
strategies for treating EHEC infections in humans.  
Since VT represents the major virulence factor in EHEC, identification of antivirulence 
agents such as toxin neutralizers or inhibitors will lead to the development more specific and 
efficacious therapeutic strategies in the treatment of EHEC associated HUS. Our previous studies 
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reported two natural molecules, rutin (RT) a phytochemical, and selenium (Se), an essential trace 
mineral, were each effective in inhibiting the synthesis of extracellular and intracellular VT 
synthesis in EHEC (Surendran Nair et al., 2016).  
Several animal models, including piglets, mice and rats have been used to investigate 
EHEC pathogenesis specifically the toxicity of VT, the pathogenesis of HUS and to some extent 
the protective capacity of different therapeutic methodologies (Sheoran et al., 2005; Armstrong et 
al., 2006; Sauter et al., 2008; Tesh et al., 1993). However, no animal model reproduces the full 
spectrum of clinical disease induced by EHEC in humans (Ritchie et al., 2013; Mohawk and 
O’Brien, 2011). Recently, the nematode Caenorhabditis elegans has been recognized as a naturally 
infected and genetic tractable animal host to study EHEC infection (Ritchie et al., 2013).  
  Several characteristics of C. elegans, including its rapid life cycle, ease of conducting 
research on host-pathogen interactions, genetic screens, and sharing of conserved innate immune 
pathways with humans make it invaluable for investigating microbial pathogenesis (Irazoqui et al., 
2010). Moreover, reports indicate that C. elegans intestinal cells share similar anatomic features 
with those of humans (McGhee, 2007), which makes it an ideal model for the study of intestinal 
pathogens, including EHEC. Studies demonstrated that EHEC can colonize and induce 
characteristic A/E (attaching and effacing) lesions in the intestine of C. elegans, and VT1 1 (Stx1) 
is partly required for the manifestation of EHEC pathogenicity (Chou et al., 2013). Additionally, 
the advantage of using C. elegans is that the pathogenic bacterium under study can be substituted 
in place of the normal feed of the nematode (E.coli OP50) as the nutritional source, and the primary 
site of the infection is the intestine. Moreover, phenotypes such as animal survival, motility, and 
pathogen burden can be easily and noninvasively examined in C. elegans (Marsh and May, 2012). 
Therefore, we used C. elegans as an in vivo model for studying the anti-EHEC activity of Se and 
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RT. Moreover, the study serves as a follow-up in vivo validation of the protective effect of Se and 
RT against EHEC in vitro (Surendran Nair et al., 2015, 2016).  
Materials and methods 
Bacterial and nematode strains. 
Young wild-type C. elegans (N2 Bristol) was used in all experiments (Caenorhabditis 
Genetics Center, MN). The nematodes were maintained on nematode growth medium agar (NGM, 
US Biologicals, MA) plates using the standard laboratory E. coli strain OP50 as feed (Brenner, 
1974). N2 strains were synchronized by isolating eggs from gravid adults, hatching the eggs 
overnight in M9 buffer, and plating L1-stage worms onto lawns of E. coli on NGM agar media. 
Worms were grown to sterile, young adults by incubating at 25°C for 48–52 h (Moy et al., 2006; 
Stiernagel, 2006).  Two strains of EHEC, namely EDL933 (ATCC 43895) which produces VT1 
and VT2, and B6914 that does not produce either VT1 or VT2 were used. For the direct 
intoxication study, we procured the Stx1 holotoxin (NR-857) from the BEI resources (Manassas, 
VA). 
Effect of Se and RT on C. elegans 
C. elegans strain N2 was grown on nematode growth medium (NGM) agar plates and fed 
with E. coli OP50 (Stiernagel, 2006). Synchronized adult nematodes were transferred to 48-well 
plates (20 worms/well), each well containing 150 μl of S medium with E. coli OP50 (Stiernagel, 
2006). Selenium (Sigma-Aldrich, St. Loius, MO) and Rutin (Sigma-Aldrich, St. Loius, MO) at 
different concentrations, were added in each well from 0% to 0.5% (v/v) with 0.01% increment. 
Dimethyl sulfoxide (DMSO, Sigma-Aldrich, St. Loius, MO) was used as the diluent for RT; the 
final concentration of DMSO was <1%.  At every 48 h of post-treatment, in order to score for 
worm survival, the plates were hand shaken, and the worms were considered dead if they did not 
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move or exhibit muscle tone (Moy et al., 2006). Living nematodes maintain a sinusoidal shape, 
whereas dead nematodes appear as straight rods (Moy et al., 2006) (Figure 1). 
C. elegans infection 
EHEC strain EDL 933 was grown overnight in Luria-Bertani (LB, Fisher Scientific) broth 
at 37°C. Bacterial lawns used for C. elegans infection assays were prepared by spreading 200 μl 
of the overnight EHEC culture on modified NGM (50 mM NaCl and 0.35% peptone) agar plates. 
The plates were incubated at 37°C for 12 h before seeding with young adult nematodes (Stiernagel, 
2006). The infections were performed at 25°C overnight.  
Survival assays of infected C. elegans treated with Se and RT 
Nematode survival was evaluated by liquid medium assay, as described previously 
(Uccelletti et al, 2010). EHEC-infected adult worms were washed three times with M9 buffer and 
transferred to 48-well plates (20 worms/well). Each well containing 150 μl of S medium with E. 
coli OP50 along with RT (Sigma-Aldrich) and Se (sodium selenite, Sigma-Aldrich) separately (at 
the highest concentration non-toxic to the worms) added to the wells.  Wells without Se and RT 
served as positive controls and uninfected worms were the negative controls. The plates were 
incubated at 25°C for 7 days. Worm survival was monitored every 48 h for 7 days, and 
survivability index was determined.  
Estimation of EHEC within the nematode gut 
The numbers of viable EHEC in the worm intestine were determined before and after RT 
treatment, as described by Uccelletti et al (2010). Briefly, for each replicate, 10 infected worms 
were transferred into a 1.5-ml Eppendorf tube and washed three times with M9 buffer (500 μl) 
containing 20 μg/ml gentamicin to remove surface E. coli. The nematodes were broken with 50 μl 
of M9 buffer-1% Triton X-100. Appropriate serial dilutions of whole worm lysate were plated on 
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Sorbitol MacConkey agar in order to determine bacterial colonization in the intestinal tract of the 
worm.  
Toxicity study on C. elegans using extracellular verotoxin 
Synchronized adult nematodes were transferred to 48-well plates (20 worms/well), each 
well containing 150 μl of S medium with E. coli OP50. A volume of 100 µl of the supernatant 
retrieved from an overnight grown EHEC EDL 933 culture (containing ~ 100 ng VT estimated 
using Premier EHEC ELISA Kit) and B6914 supernatant (tested negative for VT) were added to 
the respective wells. Worms exposed to 100 ng standard Stx1 holotoxin (BEI resources, Manassas, 
VA) were included as positive controls and those not exposed to any toxin served as negative 
controls. Worm survival was estimated every 48 h, as described above for 7 days, and the 
survivability index was determined.  
Protective effect of RT against the toxicity effects of verotoxin 
Synchronized adult nematodes were exposed to overnight culture supernatant of EDL933, 
B6914, and VT, as described above.  RT was added to the wells at concentrations identified from 
the previous experiment, and wells without RT served as positive controls. Uninfected worms 
served as negative controls. The plates will be incubated at 25°C for 7 days. Worm survival was 
estimated every 48 h as described above for 7 days and survivability index determined.  
Statistical analysis 
A completely randomized design was used for the study. All the experiments had duplicate 
samples for each treatment and control, and were replicated three times. The data were analyzed 
using the PROC MIXED procedure of the Statistical Analysis Software (SAS 9.3 version, SAS 
institute, Cary, NC).  The differences between means were compared and significance was tested 
at   P<0.05. The log-rank test was used to analyze survival curves, with a P -value of < 0.05 
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indicating statistical significance. The survival analysis experiments were performed three times 
with triplicate samples (N =180).  
Results 
Effect of Se and RT on C. elegans 
A toxicity study was first conducted to determine the in vivo lethal doses of Se and RT in 
uninfected nematodes. Accordingly, the anti-virulence concentrations determined against EHEC 
in our previous in vitro studies were found to be non-lethal in the case of RT, whereas for Se, those 
in vitro sub inhibitory concentrations were lethal. In concordance with studies conducted using 
other flavonoids such as catechin (Saul et al., 2009), 1.7 mM of RT was found to be non-lethal 
during a 7 day period of observation (Figure 1). Dimethyl sulfoxide used as the diluent for RT 
(final concentration 1%) neither affected worm survival in the non-infected group nor protected 
the worms from EHEC infection. In the case of Se, concentrations above 0.15 mM were found to 
be toxic, where the worms displayed sluggishness and delayed response within 24 h of exposure. 
Therefore in the further experiments, we used 1.7 mM RT (the in vitro anti-virulence concentration 
against EHEC) and 0.15 mM Se (~150 times lesser than the in vitro anti-virulence concentration) 
(Figure 1).  
Effect of RT and Se on the survival of EHEC infected worms 
The adult nematodes were infected with EHEC strain EDL 933 overnight and then 
transferred to S buffer containing RT or Se at the indicated concentrations. Worm survival was 
monitored every 48 h for 7 days and survivability index was determined. The results showed that 
treating EHEC infected worms with RT protected the nematode against the lethal bacterial 
infection (Figure 2). Rutin increased the infected worm survival by at least three-fold throughout 
the treatment period in liquid medium.  In addition, a difference in the activity of infected worms 
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treated with RT compared to controls was noted. The RT-treated worms were very active and 
similar to uninfected controls when compared to the sluggish infected worms. However, Se did 
not exert any anti-EHEC activity and percentage worm survival after treatment was not 
significantly different from the infected control group (Figure 3). The negative control group, 
which was neither infected nor treated, showed 100% survivability throughout the seven days. 
Based on these observations, further antivirulence mechanisms of RT against EHEC in the 
nematode were elucidated and discussed below. However, the antivirulence mechanisms of Se 
needs to be investigated in mammalian models because of the sensitivity of C. elegans to the metal. 
Effect of RT on EHEC colonization in the nematode intestinal tract 
The effect of RT on the colonization of EHEC in the intestinal lumen of C. elegans was 
further examined. EHEC colony-forming units (CFU) per nematode were determined in infected 
and treated worms. As shown in Fig. 2B, the average number of EHEC per worm recovered from 
worms infected with EDL933 overnight was ~ 4.5 log. However, the pathogen count dropped 
significantly (~ 2 log) in RT treated worms with respect to untreated infected live worms at the 
end of 7 days of observation. The retrieved EHEC on the agar plates were then confirmed as O157: 
H7 strain by using latex agglutination assay (Thermo Fisher, Waltham, MA). These results suggest 
that RT interfered with the ability of EHEC to colonize the nematode gut (Figure 4).  
Toxicity study on C. elegans using extracellular verotoxin and protective effect of RT against 
the toxicity effects of extracellular verotoxin 
Since the EDL 933 strain elaborates Stx1 and Stx2 toxins, and previous studies showed the 
association of Stx1 with EHEC pathogenesis (Chou et al. 2013), the anti-toxigenic potential of RT 
was investigated in vivo. Synchronized adult nematodes were exposed to culture supernatant of 
strains EDL933 and B6914 (does not produce either Stx1 or Stx2), and commercially available 
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standard VT (Stx1) separately, as described in the methods. Interestingly, exposure to the 
extracellular supernatant from EDL 933 produced maximal lethality compared to pure toxin and 
the supernatant retrieved from the strain B6914 (Figure 5). However, treating the worms with RT 
after intoxication did not protect the worms from EHEC infection significantly (Figure 6).   
Discussion 
C. elegans has been used widely as a host system to study the pathogenesis of various 
human pathogens, including EHEC and EPEC (Enteropathogenic E.coli) (Garsin et al. 2001; 
Nicholas and Hodgkin 2004; Chou et al. 2013). Similarly, Chou et al (2013) observed Shiga toxin-
dependent disease development and involvement of attaching and effacing lesions, both typical 
with EHEC virulence, in the nematode gut infection process. Therefore, this study was undertaken 
to validate the antivirulence effects of Se and RT observed in our previous in vitro studies 
(Surendran Nair et al., 2016). 
In concordance with other studies conducted, we first observed that EHEC could infect, 
colonize and kill C. elegans in a period of seven days (Frankel et al., 1998; Anyanful et al., 2005; 
Chou et al., 2013). We also noted that EHEC colonized and persisted in the digestive tract of C. 
elegans, and several phenotypic changes, including sluggish activity, paler appearance and dilated 
body surface were observed compared to control worms. Similar to the antimicrobial effect of RT 
against EHEC in C. elegans, Lee and coworkers (2009) observed that the green tea catechin, 
epigallocatechin gallate, protected the nematode against EHEC by inhibiting quorum sensing. 
Further, Kampkötter et al (2007) while studying the effect of RT on stress resistance in C elegans, 
observed a reduced ROS accumulation and decreased extent of induced oxidative stress with RT 
administration. A similar modulating effect of different flavonoids on oxidative stress, redox-
sensitive signaling pathways and life span in C. elegans was also reported by Koch et al (2014). 
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However, the protective effect of RT against EHEC in C. elegans was not observed when the 
worms were directly intoxicated with pure toxin or EHEC culture supernatant containing the toxin. 
Therefore, RT’s protective effect against EHEC could be attributed to the inhibition on VT 
production by the pathogen in the nematode gut, as observed in our in vitro study. On the other 
hand, despite using a RT concentration that is sub-inhibitory on EHEC, we observed significant 
decreased bacterial load in the treated worms compared to controls. This suggests that there could 
be additional mechanisms involved in the RT-mediated anti-EHEC effect conferred in the worms. 
Based on our in vitro results that showed that Se was inhibitory on VT synthesis in EHEC, 
we hypothesized that the dietary essential mineral will be effective in protecting C. elegans against 
the pathogen challenge. Previously, Li et al. (2009) reported that C. elegans infected with P. 
aeruginosa were rescued by supplementation of Se, where the protective effect was attributed to 
the upregulation of putative antimicrobial genes in the worm. However, in our studies, Se did not 
display any protective effect in the worms against EHEC challenge. This could be attributed to the 
significantly lesser Se concentration (0.15 mM) used in our worm study compared to that used in 
vitro (30mM), where VT synthesis by EHEC was significantly inhibited. Selenium at 
concentrations above 0.15 mM were found to be lethal to C. elegans in our study. Previously, 
Boehler et al. (2014) observed that Se toxicity in C. elegans causes an increase in ROS and stress 
responses, marked by increased expression of oxidoreductases and reduced expression of cuticle-
associated genes. Further, an impaired growth was observed when the worms were exposed to 
concentrations as low as 0.2 mM, thereby concurring with our findings.  
 In conclusion, the results from this study confirm that C. elegans could be used as a model 
to study EHEC pathogenesis. Further, concurring with our in vitro studies, RT exerted significant 
anti-EHEC effect in the nematode. However, Se was found to be toxic to C. elegans, and 
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considering the increased sensitivity of worms to the mineral, the protective effect of Se against 
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Figure 1: Effect of Se and RT on the survival of the nematodes.  Synchronized adult nematodes 
were fed with Se and RT to determine the non lethal concentrations in uninfected nematodes. 1.7 



















Figure 2. Effect of RT on the survival of EHEC infected worms (P<0.05). Synchronized adult 
nematodes were infected with EHEC followed by treating with 1.7 mM RT and survivability was 
observed. RT increased the infected worm survival by at least three-fold throughout the treatment 

















Figure 3. Effect of Se on the survival of EHEC-infected worms. Synchronized adult nematodes 
were infected with EHEC followed by treating with 0.15mM Se and survivability was observed. 
Se did not exert any anti-EHEC activity and percentage worm survival after treatment was not 

















Figure 4. Effect of RT on bacterial colonization in the nematode intestinal tract (P<0.05). EHEC 
colony-forming units (CFU) per nematode were determined in infected and treated worms. The 
average number of EHEC per worm recovered from worms infected with EDL933 overnight was 
~ 4.5 log. The pathogen count dropped significantly (~ 2 log) in RT treated worms with respect to 
















Figure 5. Toxicity of extracellular EHEC culture supernatants and Stx1 holotoxin on C. elegans 
(P<0.05). Synchronized adult nematodes were exposed to culture supernatant of strains EDL933 
and B6914 (does not produce either Stx1 or Stx2), and commercially available standard VT (Stx1) 
separately. Exposure to the extracellular supernatant from EDL 933 produced maximal lethality 
















Figure 6a. Protective effect of RT against the toxicity effects of culture supernatants and Stx1 
holotoxin. Synchronized adult nematodes were exposed to culture supernatant of strains EDL933 
and B6914 (does not produce either Stx1 or Stx2), and commercially available standard VT (Stx1) 
separately followed by treating with SIC of RT. Treating the worms with RT after intoxication did 
not protect the worms from EHEC infection significantly.  (P < 0.05 within the treatments between 
days and P > 0.05 between respective treatments and controls in a given day). 
 
 






























Escherichia coli O157:H7 (EHEC) is a major foodborne pathogen in the United States and 
poses a significant public health concern owing to its ability to produce fatal food-borne 
infections with a low infectious dose. The pathophysiology of EHEC infection is primarily 
mediated by verotoxins, which bind to globotriaosylceramide (Gb3) receptor on host cells, 
resulting in hemorrhagic diarrhea and kidney failure. Therefore, inhibition of EHEC toxin 
mediated pathology can significantly reduce its illness, and improve disease outcome in 
humans. This study investigated the efficacy of two natural antimicrobials selenium (Se) and 
rutin (RT), for potentially controlling EHEC outbreaks in the food continuum, and their efficacy 
as virulence inhibitors against EHEC infections in humans.  
In objective 1, the efficacy of Se in inhibiting and inactivating EHEC biofilms was 
investigated. Additionally, the effect of Se on surface attachment of planktonic cells and 
exopolysaccharide (EPS) synthesis was studied. Moreover, the efficacy of Se in combination 
with hot water for rapidly inactivating fully formed EHEC biofilms was determined. For biofilm 
inhibition assay, polystyrene plates inoculated with EHEC (∼6.0 log CFU/well) were treated 
with the sub-inhibitory concentration of Se, and incubated at 25°C and 4°C. The bacterial 
population in the biofilm was enumerated every 24 h for 96 h. Initial EHEC planktonic cell 
attachment and EPS production were analysed using solid surface assay and ruthenium red 
staining assay, respectively. The inactivation of mature EHEC biofilms was studied by treating 
pre-formed biofilms with the bactericidal concentration of Se in combination with hot water 
(80oC) for 0, 2 and 5 min. Selenium reduced attachment of planktonic cells, biofilm formation 
and EHEC EPS synthesis (P < 0.05). Se in combination with hot water reduced biofilm-
associated EHEC counts to undetectable levels at 5 min of exposure compared to control 
(P < 0.05). In addition, the coating of stainless steel surfaces with Se nanoparticles exerted 
206 
 
significant anti-biofilm effect. The results suggest that Se could potentially be incorporated on 
food contact surfaces in processing plants for controlling EHEC biofilms, and improve food 
safety. 
Objective 2 investigated the efficacy of a food-grade, plant-derived flavonoid, rutin (RT), 
either alone or in combination with chitosan, in enhancing the thermal inactivation of EHEC in 
undercooked ground beef patties. Fresh, fine ground beef (80% lean) purchased locally was 
divided into patties (25 g) and inoculated with a 5-strain mixture of EHEC (7.0 log CFU/g), 
followed by addition of RT (0.05%, 0.1%w/w) with or without CH (0.01%v/w). The patties 
were packaged on Styrofoam trays, wrapped with oxygen-permeable PVC film and stored at 
4°C for 5 days. On days 1, 3 and 5, patties were cooked to an internal temperature of 65°C and 
surviving EHEC were enumerated. The effect of treatments on meat color using MiniScan XE 
Plus colorimeter and lipid oxidation during storage was determined according to American 
Meat Sciene Association (AMSA) guidelines. RT enhanced thermal destruction of EHEC and 
reduced pathogen load by at least 3 log CFU/g compared with control (P<0.05). The 
combination of RT and CH was more effective, and reduced EHEC to undetectable levels by 
day 7 of storage (P<0.05). The EHEC counts in uncooked patties did not decline during storage 
(P>0.05). The treatments did not alter shelf-life compared with controls (P>0.05), whereas there 
was an increased redness (a* value) in patties treated with RT (P<0.05). Results suggested that 
RT could be used to kill EHEC in undercooked patties; however, sensory studies are warranted. 
In objective 3, the effect of Se on EHEC motility, verotoxin production, cytotoxicity and 
toxin gene expression was determined. Additionally, the effect of selenium on Gb3 receptor 
protein production and expression of Gb3 synthesis genes in human lymphoma cells was 
investigated by flow cytometry and real-time quantitative PCR (RT-qPCR), respectively. 
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Selenium reduced extracellular verotoxin production by 40–60% and intracellular verotoxin 
synthesis by 80-90% in EHEC (P<0.05). Selenium also inhibited toxin-mediated Vero cell 
cytotoxicity, and down-regulated the expression of EHEC verotoxin genes (P<0.05). In 
addition, mean fluorescence data from flow cytometry revealed that selenium reduced the 
production of Gb3 receptor (P<0.05) compared to untreated control. This was further validated 
by RT-qPCR data, which revealed a significant down-regulation of LacCer synthase gene 
(GalT2) involved in Gb3 synthesis. Results justify follow up in vivo studies for validating the 
efficacy of selenium in controlling EHEC infection.  
In objective 4, the efficacy of sub-inhibitory concentration (SIC, highest concentration that 
is neither bacteriostatic nor bactericidal) of RT on EHEC motility, attachment to cultured 
intestinal epithelial cells, verotoxin production and verotoxin binding to Gb3 receptor was 
investigated. In addition, the effect of RT on EHEC virulence gene expression was determined.  
Following treatment, extracellular and intracellular verotoxin concentration in each culture was 
determined by enzyme linked immunosorbent assay.  In addition, the effect of RT on the 
expression of EHEC virulence genes, including the verotoxin genes (stx1 and stx2) was 
investigated using real-time quantitative polymerase chain reaction (RT-qPCR). The effect of 
RT on EHEC motility and adhesion to human intestinal epithelial cells (CaCO2) was also 
studied using standard protocols. Rutin decreased EHEC motility and attachment to CaCO2 
cells (P<0.05). Rutin inhibited both extracellular and intracellular verotoxin production by 70-
80% in all three EHEC strains tested, compared to the untreated controls (P < 0.05).  RT-qPCR 
results revealed that RT down-regulated the transcription of verotoxin gens, stx1 and stx2 (P < 
0.05). Verotoxin binding to Gb3 receptor was decreased in the presence of RT (P < 0.05). 
Verotoxin binding to Gb3 receptor was decreased in the presence of RT (P < 0.05). Further 
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experiments revealed that RT can competitively bind VT at the receptor binding sites, thereby 
possibly inhibiting toxin-induced pathology. 
 Caenorhabditis elegans, a free-living nematode with a rapid generation time, has been 
extensively used as an in vivo model in studies of microbial pathogenesis and innate immunity. 
C. elegans has been used as an infection model for several enteric pathogens, including EHEC, 
enteropathogenic E. coli, and Salmonella. The advantage of using C. elegans is that the 
pathogenic bacterium under study can be substituted in place of the normal feed of the nematode 
(Escherichia coli OP50) as the nutritional source, and the primary site of the infection is the 
intestine. Moreover, phenotypes such as animal survival, motility, and pathogen burden can be 
easily and noninvasively examined in C. elegans. Additionally, reports suggest that C. elegans 
intestinal cells share similar anatomic features with humans, which makes it an ideal model for 
the study of intestinal pathogens, including EHEC. Therefore, in objective 5, we used C. elegans 
as an in vivo model for studying the anti-EHEC activity of Se and RT. 
A toxicity study was first conducted to determine the in vivo lethal doses of Se and RT in 
uninfected nematodes. The in vitro anti-virulence concentrations determined against EHEC in 
our previous studies found to be not lethal to the worms in the case of RT, whereas for Se the 
sub inhibitory concentration determined in vitro was found to be lethal. Further, in this study, 
RT increased the survivability of EHEC-infected worms ~ 65% compared to control. 
Furthermore, the ability of EHEC to colonize in the nematode was impeded after treating with 
RT. On the other hand, Se lacked anti-EHEC activity and the percentage survival of worms 
after treatment with the mineral was not significantly different from the infected control group.  
Mechanisms of the pathogen is gaining much more interest in this decade of antibiotic 
resistance. In conclusion, this Ph.D. dissertation targeted to attenuate the virulence mechanisms 
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of EHEC, particularly the verotoxins, using two classes of natural antimicrobials, RT and Se. 
In addition, the efficacy of RT and Se for controlling EHEC in ground beef and food contact 
surfaces, respectively was investigated. The study expected to yield potential new strategies for 
reducing the risks due to this pathogen to humans.  
 
